Iveda Solutions, Inc. IVDAW Financial Statement Data


2025 Q2

Submissions

Field Row 1 Row 2 Row 3
adsh 0001641172-25-015284 0001641172-25-009950 0001641172-25-004833
cik 1397183 1397183 1397183
name IVEDA SOLUTIONS, INC. IVEDA SOLUTIONS, INC. IVEDA SOLUTIONS, INC.
sic 7372 7372 7372
countryba US US US
stprba AZ AZ AZ
cityba MESA MESA MESA
zipba 85204 85204 85204
bas1 1744 S. VAL VISTA DRIVE 1744 S. VAL VISTA DRIVE 1744 S. VAL VISTA DRIVE
bas2 STE. 213 STE. 213 STE. 213
baph 480 338-1576 480 338-1576 480 338-1576
countryma US US US
stprma AZ AZ AZ
cityma MESA MESA MESA
zipma 85204 85204 85204
mas1 1744 S. VAL VISTA DRIVE 1744 S. VAL VISTA DRIVE 1744 S. VAL VISTA DRIVE
mas2 STE. 213 STE. 213 STE. 213
countryinc US US US
stprinc NV NV NV
ein 202222203 202222203 202222203
former IVEDA CORP IVEDA CORP IVEDA CORP
changed 20090916 20090916 20090916
afs 4-NON 4-NON 4-NON
wksi 0 0 0
fye 1231 1231 1231
form 10-K/A 10-Q 10-K
period 20241231 20250331 20241231
fy 2024 2025 2024
fp FY Q1 FY
filed 20250616 20250513 20250415
accepted 2025-06-16 17:01:00.0 2025-05-13 16:15:00.0 2025-04-15 16:44:00.0
prevrpt 0 0 0
detail 1 1 1
instance form10-ka_htm.xml form10-q_htm.xml form10-k_htm.xml
nciks 1 1 1
aciks

Description
Field Name Field Description
adsh Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission.
cik Central Index Key (CIK). Ten digit number assigned by the SEC to each registrant that submits filings.
name Name of registrant. This corresponds to the name of the legal entity as recorded in EDGAR as of the filing date.
sic Standard Industrial Classification (SIC). Four digit code assigned by the SEC as of the filing date, indicating the registrant’s type of business.
countryba The ISO 3166-1 country of the registrant's business address.
stprba The state or province of the registrant’s business address, if field countryba is US or CA.
cityba The city of the registrant's business address.
zipba The zip code of the registrant’s business address.
bas1 The first line of the street of the registrant’s business address.
bas2 The second line of the street of the registrant’s business address.
baph The phone number of the registrant’s business address.
countryma The ISO 3166-1 country of the registrant's mailing address.
stprma The state or province of the registrant’s mailing address, if field countryma is US or CA.
cityma The city of the registrant's mailing address.
zipma The zip code of the registrant’s mailing address.
mas1 The first line of the street of the registrant’s mailing address.
mas2 The second line of the street of the registrant’s mailing address.
countryinc The ISO 3166-1 country of incorporation for the registrant.
stprinc The state or province of incorporation for the registrant, if countryinc is US or CA.
ein Employee Identification Number, 9 digit identification number assigned by the Internal Revenue Service to business entities operating in the United States.
former Most recent former name of the registrant, if any.
changed Date of change from the former name, if any.
afs Filer status with the SEC at the time of submission:
1-LAF=Large Accelerated, 2-ACC=Accelerated, 3-SRA=Smaller Reporting Accelerated, 4-NON=Non-Accelerated, 5-SML=Smaller Reporting Filer, NULL=not assigned.
wksi Well Known Seasoned Issuer (WKSI). An issuer that meets specific SEC requirements at some point during a 60-day period preceding the date the issuer satisfies its obligation to update its shelf registration statement.
fye Fiscal Year End Date, rounded to nearest month-end.
form The submission type of the registrant’s filing.
period Balance Sheet Date, rounded to nearest month-end.
fy Fiscal Year Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8).
fp Fiscal Period Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8) within Fiscal Year.
filed The date of the registrant’s filing with the Commission.
accepted The acceptance date and time of the registrant’s filing with the Commission.
prevrpt Previous Report – TRUE indicates that the submission information was subsequently amended.
detail TRUE indicates that the XBRL submission contains quantitative disclosures within the footnotes and schedules at the required detail level (e.g., each amount).
instance The name of the submitted XBRL Instance Document. The name often begins with the company ticker symbol.
nciks Number of Central Index Keys (CIK) of registrants (i.e., business units) included in the consolidating entity’s submitted filing.
aciks Additional CIKs of co-registrants included in a consolidating entity’s EDGAR submission, separated by spaces. If there are no other co-registrants (i.e., nciks=1), the value of aciks is NULL. For a very small number of filers, the entire list of co-registrants is too long to fit in the field. Where this is the case, users should refer to the complete submission file for all CIK information.

Numbers

adsh ddate tag value uom qtrs version segments coreg footnote
0001641172-25-015284 20241231 Stock Issued During Period Shares Issued For Services 12500.0000 shares 4 us-gaap/2024
0001641172-25-015284 20231231 Earnings Per Share Basic -2.0700 USD 4 us-gaap/2024
0001641172-25-015284 20231231 Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations 528.0000 USD 4 us-gaap/2024 Restatement= Revision Of Prior Period Reclassification Adjustment;
0001641172-25-015284 20231231 Gross Profit 1067604.0000 USD 4 us-gaap/2024
0001641172-25-015284 20241231 Gross Profit 1301634.0000 USD 4 us-gaap/2024
0001641172-25-015284 20241231 Income Loss From Equity Method Investments USD 4 us-gaap/2024
0001641172-25-015284 20231231 Increase Decrease In Other Accounts Payable -1173.0000 USD 4 us-gaap/2024 Restatement= Revision Of Prior Period Reclassification Adjustment; An adjustment for $180,000 to expense its investment in Iveda Phils JV originally recorded as a consolidation but we have determined this investment should have been recorded as the equity method. The net loss effect is $180,000 less the $65,070 loss recorded in 2023 in consolidation. Net $114,930 additional loss recorded in 2023.
0001641172-25-015284 20231231 Net Income Loss USD 4 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001641172-25-015284 20231231 Net Income Loss -4142666.0000 USD 4 us-gaap/2024 Equity Components= Retained Earnings;
0001641172-25-015284 20231231 Operating Expenses 1005269.0000 USD 4 us-gaap/2024 Geographical= T W;
0001641172-25-015284 20231231 Operating Expenses 4103210.0000 USD 4 us-gaap/2024 Geographical= U S;
0001641172-25-015284 20241231 Operating Expenses 1015109.0000 USD 4 us-gaap/2024 Geographical= T W;
0001641172-25-015284 20231231 Other Comprehensive Income Loss Net Of Tax -775.0000 USD 4 us-gaap/2024
0001641172-25-015284 20231231 Other Comprehensive Income Loss Net Of Tax USD 4 us-gaap/2024 Equity Components= Common Stock;
0001641172-25-015284 20241231 Other Comprehensive Income Loss Net Of Tax USD 4 us-gaap/2024 Equity Components= Common Stock;
0001641172-25-015284 20241231 Other Comprehensive Income Loss Net Of Tax USD 4 us-gaap/2024 Equity Components= Retained Earnings;
0001641172-25-015284 20250228 Preferred Stock Shares Issued 12500000.0000 shares 0 us-gaap/2024
0001641172-25-015284 20241231 Proceeds From Repayments Of Short Term Debt 78254.0000 USD 4 us-gaap/2024
0001641172-25-015284 20241231 Revenue From Contract With Customer Excluding Assessed Tax 869261.0000 USD 4 us-gaap/2024 Geographical= U S;
0001641172-25-015284 20231231 Selling General And Administrative Expense 4311367.0000 USD 4 us-gaap/2024
0001641172-25-015284 20221231 Shares Outstanding 1883342.0000 shares 0 us-gaap/2024 Equity Components= Common Stock;
0001641172-25-015284 20221231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest -220643.0000 USD 0 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income; Restatement= Restated;
0001641172-25-015284 20221231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest -222380.0000 USD 0 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income; Restatement= Restatement Adjustment;
0001641172-25-015284 20221231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest -47941796.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings; Restatement= Restatement Adjustment;
0001641172-25-015284 20241231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 55962337.0000 USD 0 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001641172-25-015284 20241231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest -53176717.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings;
0001641172-25-015284 20241231 Stock Issued During Period Shares New Issues 656250.0000 shares 4 us-gaap/2024 Plan Name= Two Thousand Twenty Plan;
0001641172-25-015284 20231231 Stock Issued During Period Value Issued For Services 138546.0000 USD 4 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001641172-25-015284 20241231 Stock Issued During Period Value Issued For Services 90000.0000 USD 4 us-gaap/2024
0001641172-25-015284 20241231 Stock Issued During Period Value New Issues 6.0000 USD 4 us-gaap/2024 Equity Components= Common Stock;
0001641172-25-015284 20231231 Stock Issued During Period Value Stock Warrants Exercised USD 4 0001641172-25-015284 Equity Components= Retained Earnings;
0001641172-25-015284 20241231 Stock Issued During Reverse Split Fractional Shares 149335.0000 shares 4 0001641172-25-015284 Equity Components= Common Stock;
0001641172-25-004833 20231231 Accounts Payable And Other Accrued Liabilities Current 1110087.0000 USD 0 us-gaap/2024 Restatement= Scenario Previously Reported;
0001641172-25-015284 20231231 Accounts Payable And Other Accrued Liabilities Current 1110087.0000 USD 0 us-gaap/2024 Restatement= Scenario Previously Reported;
0001641172-25-015284 20231231 Accumulated Other Comprehensive Income Loss Net Of Tax -222380.0000 USD 0 us-gaap/2024 Restatement= Scenario Previously Reported;
0001641172-25-015284 20231231 Adjustments To Additional Paid In Capital Warrant Issued USD 4 us-gaap/2024 Equity Components= Retained Earnings;
0001641172-25-015284 20231231 Cash And Cash Equivalents At Carrying Value 4738504.0000 USD 0 us-gaap/2024
0001641172-25-015284 20241231 Cash And Cash Equivalents At Carrying Value 1025675.0000 TWD 0 us-gaap/2024
0001641172-25-015284 20231231 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect -2557499.0000 USD 4 us-gaap/2024 Restatement= Scenario Previously Reported;
0001641172-25-015284 20240930 Common Stock Par Or Stated Value Per Share 0.0000 USD 0 us-gaap/2024 Equity Components= Common Stock;
0001641172-25-015284 20250228 Common Stock Par Or Stated Value Per Share 0.0000 USD 0 us-gaap/2024 Subsequent Event Type= Subsequent Event; Type Of Arrangement= At The Market Offering Agreement;
0001641172-25-015284 20231231 Common Stock Shares Issued 2021236.0000 shares 0 us-gaap/2024
0001641172-25-015284 20241231 Common Stock Value 28.0000 USD 0 us-gaap/2024
0001641172-25-015284 20241231 Common Stock Warrants Issued For Services USD 4 0001641172-25-015284
0001641172-25-015284 20241231 Depreciation Depletion And Amortization 31805.0000 USD 4 us-gaap/2024
0001641172-25-009950 20240331 Accounts Payable And Other Accrued Liabilities Current 200000.0000 USD 0 us-gaap/2024 Restatement= Revision Of Prior Period Reclassification Adjustment;
0001641172-25-009950 20240331 Accounts Payable And Other Accrued Liabilities Current 1101491.0000 USD 0 us-gaap/2024 Restatement= Scenario Previously Reported;
0001641172-25-009950 20250331 Assets 4528325.0000 USD 0 us-gaap/2024
0001641172-25-009950 20241231 Assets Current 5026415.0000 USD 0 us-gaap/2024
0001641172-25-009950 20241231 Common Stock Par Or Stated Value Per Share 0.0000 USD 0 us-gaap/2024
0001641172-25-009950 20240331 Cost Of Revenue 164886.0000 USD 1 us-gaap/2024
0001641172-25-009950 20240331 Depreciation Depletion And Amortization 7900.0000 USD 1 us-gaap/2024
0001641172-25-009950 20240331 Earnings Per Share Diluted -0.5700 USD 1 us-gaap/2024 Restatement= Scenario Previously Reported;
0001641172-25-009950 20250331 Gross Profit 233413.0000 USD 1 us-gaap/2024 Geographical= T W;
0001641172-25-009950 20240331 Increase Decrease In Accounts Receivable -67390.0000 USD 1 us-gaap/2024
0001641172-25-009950 20250331 Increase Decrease In Deferred Charges -147920.0000 USD 1 us-gaap/2024
0001641172-25-009950 20240331 Increase Decrease In Other Accounts Payable 51090.0000 USD 1 us-gaap/2024
0001641172-25-009950 20240331 Increase Decrease In Right Of Use Asset USD 1 0001641172-25-009950
0001641172-25-009950 20241231 Liabilities 2674077.0000 USD 0 us-gaap/2024
0001641172-25-009950 20241231 Liabilities And Stockholders Equity 5179516.0000 USD 0 us-gaap/2024
0001641172-25-009950 20240331 Net Cash Provided By Used In Investing Activities 188400.0000 USD 1 us-gaap/2024 Restatement= Revision Of Prior Period Reclassification Adjustment;
0001641172-25-009950 20240331 Net Cash Provided By Used In Operating Activities -1293473.0000 USD 1 us-gaap/2024
0001641172-25-009950 20240331 Nonoperating Income Expense 73628.0000 USD 1 us-gaap/2024
0001641172-25-009950 20240331 Operating Expenses 1513759.0000 USD 1 us-gaap/2024
0001641172-25-009950 20240331 Operating Expenses 1513759.0000 USD 1 us-gaap/2024 Restatement= Restated;
0001641172-25-009950 20250331 Operating Expenses 1123770.0000 USD 1 us-gaap/2024
0001641172-25-009950 20250331 Operating Expenses 181957.0000 USD 1 us-gaap/2024 Geographical= T W;
0001641172-25-009950 20240331 Operating Income Loss -1282752.0000 USD 1 us-gaap/2024 Geographical= U S;
0001641172-25-009950 20250331 Operating Income Loss 51456.0000 USD 1 us-gaap/2024 Geographical= T W;
0001641172-25-009950 20250331 Other Comprehensive Income Loss Net Of Tax USD 1 us-gaap/2024 Equity Components= Common Stock;
0001641172-25-009950 20240331 Other Nonoperating Income Expense 25318.0000 USD 1 us-gaap/2024
0001641172-25-009950 20240331 Proceeds From Repayments Of Notes Payable 615254.0000 USD 1 us-gaap/2024
0001641172-25-009950 20240331 Property Plant And Equipment Net 1071249.0000 USD 0 us-gaap/2024 Restatement= Scenario Previously Reported;
0001641172-25-009950 20250331 Research And Development Expense USD 1 us-gaap/2024 Geographical= T W;
0001641172-25-009950 20241231 Restricted Cash 29013.0000 USD 0 us-gaap/2024 Related Party Transactions By Related Party= Shanghai Bank;
0001641172-25-009950 20250331 Restricted Cash 28606.0000 USD 0 us-gaap/2024
0001641172-25-009950 20250331 Retained Earnings Accumulated Deficit -53970389.0000 USD 0 us-gaap/2024
0001641172-25-009950 20250331 Revenue From Contract With Customer Excluding Assessed Tax 666394.0000 USD 1 us-gaap/2024 Contract With Customer Sales Channel= Commercial Enterprises;
0001641172-25-009950 20241231 Short Term Borrowings 427025.0000 USD 0 us-gaap/2024
0001641172-25-009950 20241231 Short Term Borrowings 183011.0000 USD 0 us-gaap/2024 Related Party Transactions By Related Party= Shanghai Bank;
0001641172-25-009950 20250331 Short Term Borrowings 464934.0000 USD 0 us-gaap/2024
0001641172-25-009950 20250331 Short Term Borrowings 150367.0000 USD 0 us-gaap/2024 Related Party Transactions By Related Party= Chang Hwa Bank;
0001641172-25-009950 20231231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 20.0000 USD 0 us-gaap/2024 Equity Components= Common Stock;
0001641172-25-009950 20231231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest -49195897.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings;
0001641172-25-009950 20250331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 55962337.0000 USD 0 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001641172-25-009950 20250331 Weighted Average Number Of Shares Outstanding Basic 2808071.0000 shares 1 us-gaap/2024
0001641172-25-015284 20231231 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value USD 4 us-gaap/2024 Equity Components= Retained Earnings;
0001641172-25-015284 20241231 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value USD 4 us-gaap/2024 Equity Components= Retained Earnings;
0001641172-25-015284 20231231 Adjustments To Additional Paid In Capital Warrant Issued USD 4 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001641172-25-015284 20241231 Assets Current 5026415.0000 USD 0 us-gaap/2024
0001641172-25-015284 20231231 Cash And Cash Equivalents At Carrying Value -16093.0000 USD 0 us-gaap/2024 Restatement= Revision Of Prior Period Reclassification Adjustment;
0001641172-25-015284 20231231 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations 4754596.0000 USD 0 us-gaap/2024 Restatement= Scenario Previously Reported;
0001641172-25-015284 20231231 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect -2573540.0000 USD 4 us-gaap/2024 Restatement= Restated;
0001641172-25-015284 20231231 Common Stock Par Or Stated Value Per Share 0.0000 USD 0 us-gaap/2024
0001641172-25-015284 20241231 Common Stock Par Or Stated Value Per Share 0.0000 USD 0 us-gaap/2024
0001641172-25-015284 20231231 Gain Loss On Investments 180000.0000 USD 4 us-gaap/2024 Restatement= Restated;
0001641172-25-015284 20231231 Gain Loss On Investments 180000.0000 USD 4 us-gaap/2024 Restatement= Revision Of Prior Period Reclassification Adjustment;
0001641172-25-015284 20231231 Gross Profit 1148336.0000 USD 4 us-gaap/2024 Geographical= T W;
0001641172-25-015284 20241231 Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest 58812.0000 USD 4 us-gaap/2024 Geographical= T W;
0001641172-25-015284 20231231 Income Loss From Equity Method Investments -180000.0000 USD 4 us-gaap/2024
0001641172-25-015284 20241231 Income Taxes Paid Net 38544.0000 USD 4 us-gaap/2024
0001641172-25-015284 20231231 Income Tax Expense Benefit 18308.0000 USD 4 us-gaap/2024
0001641172-25-015284 20241231 Income Tax Expense Benefit 32385.0000 USD 4 us-gaap/2024
0001641172-25-015284 20241231 Interest Paid Net 15316.0000 USD 4 us-gaap/2024
0001641172-25-015284 20241231 Long Term Debt 498195.0000 USD 0 us-gaap/2024 Related Party Transactions By Related Party= Chang Hwa Bank;
0001641172-25-015284 20231231 Net Cash Provided By Used In Financing Activities 924100.0000 USD 4 us-gaap/2024 Restatement= Scenario Previously Reported;
0001641172-25-015284 20231231 Net Cash Provided By Used In Operating Activities -3333360.0000 USD 4 us-gaap/2024
0001641172-25-015284 20241231 Net Cash Provided By Used In Operating Activities -4419748.0000 USD 4 us-gaap/2024
0001641172-25-015284 20241231 Net Income Loss -3980820.0000 USD 4 us-gaap/2024
0001641172-25-015284 20241231 Operating Expenses 5371937.0000 USD 4 us-gaap/2024
0001641172-25-015284 20231231 Operating Income Loss -4040875.0000 USD 4 us-gaap/2024
0001641172-25-015284 20241231 Operating Income Loss 32274.0000 USD 4 us-gaap/2024 Geographical= T W;
0001641172-25-015284 20241231 Other Comprehensive Income Loss Net Of Tax -58791.0000 USD 4 us-gaap/2024
0001641172-25-015284 20231231 Preferred Stock Shares Authorized 500.0000 shares 0 us-gaap/2024 Class Of Stock= Series B Preferred Stock;
0001641172-25-015284 20241231 Preferred Stock Shares Authorized 1250000.0000 shares 0 us-gaap/2024 Class Of Stock= Series A Preferred Stock;
0001641172-25-015284 20241231 Preferred Stock Shares Authorized 500.0000 shares 0 us-gaap/2024 Class Of Stock= Series B Preferred Stock;
0001641172-25-015284 20241231 Preferred Stock Shares Authorized 12500000.0000 shares 0 us-gaap/2024 Range= Maximum;
0001641172-25-015284 20231231 Preferred Stock Value USD 0 us-gaap/2024 Class Of Stock= Series B Preferred Stock;
0001641172-25-015284 20241231 Preferred Stock Value USD 0 us-gaap/2024 Class Of Stock= Series B Preferred Stock;
0001641172-25-015284 20231231 Property Plant And Equipment Net 1308914.0000 USD 0 us-gaap/2024 Balance Sheet Location= Accounts Payable And Accrued Liabilities; Restatement= Restated;
0001641172-25-015284 20231231 Property Plant And Equipment Net 891187.0000 USD 0 us-gaap/2024 Restatement= Scenario Previously Reported;
0001641172-25-015284 20231231 Revenue From Contract With Customer Excluding Assessed Tax 156701.0000 USD 4 us-gaap/2024 Contract With Customer Sales Channel= Municipalities;
0001641172-25-015284 20241231 Revenue From Contract With Customer Excluding Assessed Tax 4675122.0000 USD 4 us-gaap/2024 Contract With Customer Sales Channel= Commercial Enterprises;
0001641172-25-015284 20241231 Short Term Borrowings 183011.0000 USD 0 us-gaap/2024 Related Party Transactions By Related Party= Shanghai Bank;
0001641172-25-015284 20211231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest -220643.0000 USD 0 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income; Restatement= Restatement Adjustment;
0001641172-25-015284 20211231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 52497045.0000 USD 0 us-gaap/2024 Equity Components= Additional Paid In Capital; Restatement= Restatement Adjustment;
0001641172-25-015284 20211231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest -44706671.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings; Restatement= Restatement Adjustment;
0001641172-25-015284 20231231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest -49195897.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings;
0001641172-25-015284 20231231 Stock Issued During Period Shares Issued For Services 19656.0000 shares 4 us-gaap/2024
0001641172-25-015284 20241231 Stock Issued During Period Shares New Issues 625000.0000 shares 4 us-gaap/2024 Equity Components= Common Stock;
0001641172-25-015284 20231231 Stock Issued During Period Value Stock Warrants Exercised 1.0000 USD 4 0001641172-25-015284 Equity Components= Common Stock;
0001641172-25-015284 20241231 Stock Issued During Reverse Split Fractional Shares Value 2.0000 USD 4 0001641172-25-015284 Equity Components= Common Stock;
0001641172-25-015284 20231231 Weighted Average Number Of Diluted Shares Outstanding 1996678.0000 shares 4 us-gaap/2024
0001641172-25-004833 20231231 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value USD 4 us-gaap/2024 Equity Components= Common Stock;
0001641172-25-004833 20241231 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value USD 4 us-gaap/2024 Equity Components= Common Stock;
0001641172-25-004833 20241231 Assets 5179516.0000 USD 0 us-gaap/2024
0001641172-25-004833 20231231 Assets Current 5909427.0000 USD 0 us-gaap/2024
0001641172-25-004833 20231231 Cash And Cash Equivalents At Carrying Value 1959399.0000 TWD 0 us-gaap/2024
0001641172-25-004833 20231231 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations 4868282.0000 USD 0 us-gaap/2024
0001641172-25-004833 20241231 Common Stock Shares Issued 2808071.0000 shares 0 us-gaap/2024
0001641172-25-004833 20231231 Common Stock Value 20.0000 USD 0 us-gaap/2024
0001641172-25-004833 20231231 Comprehensive Income Net Of Tax -4143441.0000 USD 4 us-gaap/2024
0001641172-25-004833 20241231 Comprehensive Income Net Of Tax -4039612.0000 USD 4 us-gaap/2024
0001641172-25-004833 20231231 Earnings Per Share Diluted -2.0700 USD 4 us-gaap/2024
0001641172-25-004833 20231231 Earnings Per Share Diluted 2.0700 USD 4 us-gaap/2024 Restatement= Restated;
0001641172-25-004833 20231231 Gross Profit -80732.0000 USD 4 us-gaap/2024 Geographical= U S;
0001641172-25-004833 20241231 Gross Profit 254251.0000 USD 4 us-gaap/2024 Geographical= U S;
0001641172-25-004833 20231231 Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest -4268395.0000 USD 4 us-gaap/2024 Geographical= U S;
0001641172-25-004833 20241231 Increase Decrease In Deferred Charges 507308.0000 USD 4 us-gaap/2024
0001641172-25-004833 20231231 Increase Decrease In Other Accounts Payable -523633.0000 USD 4 us-gaap/2024
0001641172-25-004833 20240131 Long Term Debt 600000.0000 USD 0 us-gaap/2024 Longterm Debt Type= Term Loan;
0001641172-25-004833 20231231 Net Cash Provided By Used In Financing Activities 4868282.0000 USD 4 us-gaap/2024 Income Statement Location= Restated; Restatement= Revision Of Prior Period Reclassification Adjustment;
0001641172-25-004833 20231231 Net Cash Provided By Used In Investing Activities -265593.0000 USD 4 us-gaap/2024
0001641172-25-004833 20231231 Net Cash Provided By Used In Investing Activities -878205.0000 USD 4 us-gaap/2024 Restatement= Scenario Previously Reported;
0001641172-25-004833 20231231 Net Cash Provided By Used In Operating Activities -114930.0000 USD 4 us-gaap/2024 Income Statement Location= Additional Loss From Joint Venture; Restatement= Revision Of Prior Period Reclassification Adjustment;
0001641172-25-004833 20231231 Net Cash Provided By Used In Operating Activities -1173.0000 USD 4 us-gaap/2024 Income Statement Location= Increase Decrease In Accounts And Other Payable; Restatement= Revision Of Prior Period Reclassification Adjustment;
0001641172-25-004833 20231231 Net Income Loss USD 4 us-gaap/2024 Equity Components= Common Stock;
0001641172-25-004833 20241231 Net Income Loss USD 4 us-gaap/2024 Equity Components= Common Stock;
0001641172-25-004833 20231231 Nonoperating Income Expense -83483.0000 USD 4 us-gaap/2024
0001641172-25-004833 20231231 Operating Expenses 5108479.0000 USD 4 us-gaap/2024
0001641172-25-004833 20231231 Operating Income Loss 143068.0000 USD 4 us-gaap/2024 Geographical= T W;
0001641172-25-004833 20231231 Other Assets Noncurrent 298163.0000 USD 0 us-gaap/2024
0001641172-25-004833 20231231 Other Comprehensive Income Loss Net Of Tax USD 4 us-gaap/2024 Equity Components= Retained Earnings;
0001641172-25-004833 20231231 Payments To Acquire Property Plant And Equipment 878205.0000 USD 4 us-gaap/2024 Restatement= Scenario Previously Reported;
0001641172-25-004833 20241231 Preferred Stock Par Or Stated Value Per Share 0.0000 USD 0 us-gaap/2024
0001641172-25-004833 20241231 Proceeds From Issuance Of Common Stock 1683970.0000 USD 4 us-gaap/2024
0001641172-25-004833 20241231 Proceeds From Repayments Of Notes Payable 498195.0000 USD 4 us-gaap/2024
0001641172-25-004833 20231231 Revenue From Contract With Customer Excluding Assessed Tax 6495865.0000 USD 4 us-gaap/2024
0001641172-25-004833 20231231 Revenue From Contract With Customer Excluding Assessed Tax 88047.0000 USD 4 us-gaap/2024 Contract With Customer Sales Channel= Distributors;
0001641172-25-004833 20241231 Revenue From Contract With Customer Excluding Assessed Tax 762660.0000 USD 4 us-gaap/2024 Contract With Customer Sales Channel= Distributors;
0001641172-25-004833 20241231 Revenue From Contract With Customer Excluding Assessed Tax 170467.0000 USD 4 us-gaap/2024 Contract With Customer Sales Channel= Municipalities;
0001641172-25-004833 20241231 Revenue From Contract With Customer Excluding Assessed Tax 5151378.0000 USD 4 us-gaap/2024 Geographical= T W;
0001641172-25-004833 20241231 Share Based Compensation 122600.0000 USD 4 us-gaap/2024 Geographical= U S;
0001641172-25-004833 20211231 Shares Outstanding 1883342.0000 shares 0 us-gaap/2024 Equity Components= Common Stock; Restatement= Restatement Adjustment;
0001641172-25-004833 20241231 Shares Outstanding 2808071.0000 shares 0 us-gaap/2024 Equity Components= Common Stock;
0001641172-25-004833 20231231 Short Term Borrowings 97777.0000 USD 0 us-gaap/2024 Related Party Transactions By Related Party= Hua Nam Bank;
0001641172-25-004833 20221231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 7223190.0000 USD 0 us-gaap/2024
0001641172-25-004833 20221231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 54065775.0000 USD 0 us-gaap/2024 Equity Components= Additional Paid In Capital; Restatement= Restatement Adjustment;
0001641172-25-004833 20221231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 19.0000 USD 0 us-gaap/2024 Equity Components= Common Stock; Restatement= Restated;
0001641172-25-004833 20221231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest -45053171.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings; Restatement= Restated;
0001641172-25-004833 20221231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 7223190.0000 USD 0 us-gaap/2024 Restatement= Restated;
0001641172-25-004833 20231231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest -221418.0000 USD 0 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001641172-25-004833 20231231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 54065775.0000 USD 0 us-gaap/2024 Equity Components= Additional Paid In Capital; Restatement= Restated;
0001641172-25-004833 20241231 Stock Issued During Period Shares Issued For Services 12500.0000 shares 4 us-gaap/2024 Equity Components= Common Stock;
0001641172-25-004833 20231231 Stock Issued During Period Shares Stock Warrants Exercised 118238.0000 shares 4 0001641172-25-004833
0001641172-25-004833 20231231 Stock Issued During Period Value Issued For Services USD 4 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001641172-25-004833 20231231 Stock Issued During Period Value Issued For Services USD 4 us-gaap/2024 Equity Components= Common Stock;
0001641172-25-004833 20241231 Stock Issued During Period Value Issued For Services USD 4 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001641172-25-004833 20241231 Stock Issued During Period Value Issued For Services USD 4 us-gaap/2024 Equity Components= Common Stock;
0001641172-25-004833 20231231 Stock Issued During Period Value Stock Warrants Exercised 1322885.0000 USD 4 0001641172-25-004833
0001641172-25-004833 20231231 Stock Issued During Period Value Stock Warrants Exercised 1322884.0000 USD 4 0001641172-25-004833 Equity Components= Additional Paid In Capital;
0001641172-25-004833 20231231 Accumulated Other Comprehensive Income Loss Net Of Tax -221418.0000 USD 0 us-gaap/2024
0001641172-25-004833 20231231 Accumulated Other Comprehensive Income Loss Net Of Tax -222380.0000 USD 0 us-gaap/2024 Restatement= Scenario Previously Reported;
0001641172-25-004833 20241231 Accumulated Other Comprehensive Income Loss Net Of Tax -280209.0000 USD 0 us-gaap/2024
0001641172-25-004833 20231231 Additional Paid In Capital 54065775.0000 USD 0 us-gaap/2024
0001641172-25-004833 20231231 Adjustments To Additional Paid In Capital Warrant Issued 2700.0000 USD 4 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001641172-25-004833 20231231 Adjustments To Additional Paid In Capital Warrant Issued USD 4 us-gaap/2024 Equity Components= Retained Earnings;
0001641172-25-004833 20241231 Cash And Cash Equivalents At Carrying Value 1025675.0000 TWD 0 us-gaap/2024
0001641172-25-004833 20231231 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect -2557499.0000 USD 4 us-gaap/2024 Restatement= Scenario Previously Reported;
0001641172-25-004833 20231231 Common Stock Shares Authorized 300000000.0000 shares 0 us-gaap/2024
0001641172-25-004833 20241231 Common Stock Shares Authorized 300000000.0000 shares 0 us-gaap/2024
0001641172-25-004833 20241231 Common Stock Warrants Issued For Services USD 4 0001641172-25-004833
0001641172-25-004833 20231231 Deferred Income Tax Effects To Equity Prior Period Adjustment USD 4 0001641172-25-004833 Equity Components= Additional Paid In Capital; Restatement= Scenario Previously Reported;
0001641172-25-004833 20231231 Deferred Income Tax Effects To Equity Prior Period Adjustment 346560.0000 USD 4 0001641172-25-004833 Restatement= Scenario Previously Reported;
0001641172-25-004833 20231231 Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations 528.0000 USD 4 us-gaap/2024 Restatement= Revision Of Prior Period Reclassification Adjustment;
0001641172-25-004833 20241231 Gain Loss On Investments USD 4 us-gaap/2024
0001641172-25-004833 20241231 Gross Profit 1301634.0000 USD 4 us-gaap/2024
0001641172-25-004833 20231231 Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest 144037.0000 USD 4 us-gaap/2024 Geographical= T W;
0001641172-25-004833 20231231 Increase Decrease In Deferred Charges USD 4 us-gaap/2024
0001641172-25-004833 20241231 Increase Decrease In Other Noncurrent Assets -203693.0000 USD 4 us-gaap/2024
0001641172-25-004833 20231231 Investment Income Interest 131870.0000 USD 4 us-gaap/2024
0001641172-25-004833 20241231 Long Term Debt 376188.0000 USD 0 us-gaap/2024
0001641172-25-004833 20231231 Net Cash Provided By Used In Operating Activities -2604645.0000 USD 4 us-gaap/2024 Restatement= Scenario Previously Reported;
0001641172-25-004833 20231231 Net Income Loss -4142666.0000 USD 4 us-gaap/2024 Equity Components= Retained Earnings;
0001641172-25-004833 20241231 Nonoperating Income Expense 121868.0000 USD 4 us-gaap/2024
0001641172-25-004833 20231231 Operating Expenses 4103210.0000 USD 4 us-gaap/2024 Geographical= U S;
0001641172-25-004833 20241231 Other Comprehensive Income Loss Net Of Tax -58791.0000 USD 4 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001641172-25-004833 20231231 Preferred Stock Shares Issued 0.0000 shares 0 us-gaap/2024 Class Of Stock= Series B Preferred Stock;
0001641172-25-004833 20250228 Preferred Stock Shares Issued 12500000.0000 shares 0 us-gaap/2024
0001641172-25-004833 20231231 Research And Development Expense 4500.0000 USD 4 us-gaap/2024 Restatement= Scenario Previously Reported;
0001641172-25-004833 20231231 Retained Earnings Accumulated Deficit -47941796.0000 USD 0 us-gaap/2024 Restatement= Scenario Previously Reported;
0001641172-25-004833 20231231 Revenue From Contract With Customer Excluding Assessed Tax USD 4 us-gaap/2024 Product Or Service= Other Revenue;
0001641172-25-004833 20241231 Revenue From Contract With Customer Excluding Assessed Tax 869261.0000 USD 4 us-gaap/2024 Geographical= U S;
0001641172-25-004833 20241231 Revenue From Contract With Customer Excluding Assessed Tax USD 4 us-gaap/2024 Product Or Service= Other Revenue;
0001641172-25-004833 20231231 Selling General And Administrative Expense 4311367.0000 USD 4 us-gaap/2024
0001641172-25-004833 20231231 Short Term Borrowings 162962.0000 USD 0 us-gaap/2024 Related Party Transactions By Related Party= Chang Hwa Bank;
0001641172-25-004833 20211231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest -220643.0000 USD 0 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income; Restatement= Restatement Adjustment;
0001641172-25-004833 20221231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 52497045.0000 USD 0 us-gaap/2024 Equity Components= Additional Paid In Capital; Restatement= Scenario Previously Reported;
0001641172-25-004833 20231231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest -221418.0000 USD 0 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income; Restatement= Restated;
0001641172-25-004833 20241231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 55962337.0000 USD 0 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001641172-25-004833 20241231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 28.0000 USD 0 us-gaap/2024 Equity Components= Common Stock;
0001641172-25-004833 20250228 Stock Issued During Period Shares New Issues 312500000.0000 shares 0 us-gaap/2024 Subsequent Event Type= Subsequent Event;
0001641172-25-004833 20231231 Stock Issued During Period Value Issued For Services 138546.0000 USD 4 us-gaap/2024
0001641172-25-004833 20231231 Stock Issued During Period Value Issued For Services 138546.0000 USD 4 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001641172-25-004833 20231231 Stock Issued During Period Value Issued For Services USD 4 us-gaap/2024 Equity Components= Retained Earnings;
0001641172-25-004833 20241231 Weighted Average Number Of Diluted Shares Outstanding 2203893.0000 shares 4 us-gaap/2024
0001641172-25-004833 20231231 Accounts Payable And Other Accrued Liabilities Current USD 0 us-gaap/2024 Restatement= Restated;
0001641172-25-004833 20241231 Additional Paid In Capital 55962337.0000 USD 0 us-gaap/2024
0001641172-25-004833 20241231 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations 2658300.0000 USD 0 us-gaap/2024
0001641172-25-004833 20240930 Common Stock Par Or Stated Value Per Share 0.0000 USD 0 us-gaap/2024 Equity Components= Common Stock;
0001641172-25-004833 20241231 Cost Of Revenue 4103995.0000 USD 4 us-gaap/2024 Geographical= T W;
0001641172-25-004833 20231231 Depreciation Depletion And Amortization 19753.0000 USD 4 us-gaap/2024
0001641172-25-004833 20241231 Depreciation Depletion And Amortization 31805.0000 USD 4 us-gaap/2024
0001641172-25-004833 20231231 Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations 1780.0000 USD 4 us-gaap/2024
0001641172-25-004833 20231231 Gross Profit 1067604.0000 USD 4 us-gaap/2024
0001641172-25-004833 20241231 Gross Profit 1047383.0000 USD 4 us-gaap/2024 Geographical= T W;
0001641172-25-004833 20231231 Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest -4124358.0000 USD 4 us-gaap/2024
0001641172-25-004833 20241231 Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest 58812.0000 USD 4 us-gaap/2024 Geographical= T W;
0001641172-25-004833 20231231 Increase Decrease In Accounts Receivable -930803.0000 USD 4 us-gaap/2024
0001641172-25-004833 20241231 Increase Decrease In Accounts Receivable 996586.0000 USD 4 us-gaap/2024
0001641172-25-004833 20231231 Increase Decrease In Other Accounts Payable -523633.0000 USD 4 us-gaap/2024 Restatement= Restated;
0001641172-25-004833 20241231 Increase Decrease In Other Accounts Payable 439945.0000 USD 4 us-gaap/2024
0001641172-25-004833 20241231 Interest Expense Nonoperating 26183.0000 USD 4 us-gaap/2024
0001641172-25-004833 20240131 Long Term Debt 20000000.0000 TWD 0 us-gaap/2024 Longterm Debt Type= Term Loan;
0001641172-25-004833 20231231 Net Income Loss -3235124.0000 USD 4 us-gaap/2024 Restatement= Scenario Previously Reported;
0001641172-25-004833 20241231 Operating Expenses 1015109.0000 USD 4 us-gaap/2024 Geographical= T W;
0001641172-25-004833 20241231 Operating Expenses 4356828.0000 USD 4 us-gaap/2024 Geographical= U S;
0001641172-25-004833 20231231 Other Assets Current 435581.0000 USD 0 us-gaap/2024
0001641172-25-004833 20241231 Other Assets Current 435052.0000 USD 0 us-gaap/2024
0001641172-25-004833 20231231 Other Comprehensive Income Loss Net Of Tax USD 4 us-gaap/2024 Equity Components= Common Stock;
0001641172-25-004833 20241231 Other Comprehensive Income Loss Net Of Tax USD 4 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001641172-25-004833 20231231 Preferred Stock Shares Outstanding 0.0000 shares 0 us-gaap/2024 Class Of Stock= Series B Preferred Stock;
0001641172-25-004833 20231231 Proceeds From Repayments Of Short Term Debt -47554.0000 USD 4 us-gaap/2024
0001641172-25-004833 20241231 Proceeds From Repayments Of Short Term Debt 78254.0000 USD 4 us-gaap/2024
0001641172-25-004833 20231231 Restricted Cash 129778.0000 USD 0 us-gaap/2024
0001641172-25-004833 20231231 Revenue From Contract With Customer Excluding Assessed Tax USD 4 us-gaap/2024 Contract With Customer Sales Channel= Taiwan Government;
0001641172-25-004833 20231231 Short Term Borrowings 88032.0000 USD 0 us-gaap/2024 Related Party Transactions By Related Party= Shanghai Bank;
0001641172-25-004833 20221231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest -220643.0000 USD 0 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income; Restatement= Scenario Previously Reported;
0001641172-25-004833 20221231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest -47941796.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings; Restatement= Restatement Adjustment;
0001641172-25-004833 20221231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest -44706671.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings; Restatement= Scenario Previously Reported;
0001641172-25-004833 20221231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 7569750.0000 USD 0 us-gaap/2024 Restatement= Scenario Previously Reported;
0001641172-25-004833 20231231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 20.0000 USD 0 us-gaap/2024 Equity Components= Common Stock; Restatement= Restated;
0001641172-25-004833 20231231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest -49195897.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings; Restatement= Restated;
0001641172-25-004833 20241231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 2505439.0000 USD 0 us-gaap/2024
0001641172-25-004833 20241231 Stock Issued During Period Shares New Issues 656250.0000 shares 4 us-gaap/2024 Plan Name= Two Thousand Twenty Plan;
0001641172-25-004833 20241231 Stock Issued During Period Value New Issues 6.0000 USD 4 us-gaap/2024 Equity Components= Common Stock;
0001641172-25-004833 20231231 Stock Issued During Period Value Stock Warrants Exercised USD 4 0001641172-25-004833 Equity Components= Retained Earnings;
0001641172-25-004833 20241231 Stock Issued During Reverse Split Fractional Shares Value -2.0000 USD 4 0001641172-25-004833 Equity Components= Additional Paid In Capital;
0001641172-25-004833 20241231 Weighted Average Number Of Shares Outstanding Basic 2203893.0000 shares 4 us-gaap/2024
0001641172-25-009950 20250331 Accounts Receivable Net Current 819750.0000 USD 0 us-gaap/2024
0001641172-25-009950 20250331 Accounts Payable And Other Accrued Liabilities Current 1719848.0000 USD 0 us-gaap/2024
0001641172-25-009950 20241231 Assets 5179516.0000 USD 0 us-gaap/2024
0001641172-25-009950 20250331 Assets Current 4212653.0000 USD 0 us-gaap/2024
0001641172-25-009950 20250331 Common Stock Par Or Stated Value Per Share 0.0000 USD 0 us-gaap/2024
0001641172-25-009950 20250331 Common Stock Shares Outstanding 2808071.0000 shares 0 us-gaap/2024
0001641172-25-009950 20240331 Comprehensive Income Net Of Tax -1324187.0000 USD 1 us-gaap/2024
0001641172-25-009950 20250331 Comprehensive Income Net Of Tax -804552.0000 USD 1 us-gaap/2024
0001641172-25-009950 20240331 Gross Profit 158578.0000 USD 1 us-gaap/2024 Geographical= T W;
0001641172-25-009950 20250331 Income Tax Expense Benefit USD 1 us-gaap/2024 Geographical= U S;
0001641172-25-009950 20250331 Increase Decrease In Accounts Receivable -457885.0000 USD 1 us-gaap/2024
0001641172-25-009950 20250331 Increase Decrease In Operating Lease Liability -1137.0000 USD 1 us-gaap/2024
0001641172-25-009950 20240331 Net Income Loss USD 1 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001641172-25-009950 20240331 Net Income Loss -1289596.0000 USD 1 us-gaap/2024 Restatement= Restated;
0001641172-25-009950 20240331 Net Income Loss -181398.0000 USD 1 us-gaap/2024 Restatement= Revision Of Prior Period Reclassification Adjustment;
0001641172-25-009950 20240331 Net Income Loss -1108198.0000 USD 1 us-gaap/2024 Restatement= Scenario Previously Reported;
0001641172-25-009950 20250331 Net Income Loss USD 1 us-gaap/2024 Equity Components= Common Stock;
0001641172-25-009950 20250331 Net Income Loss 54202.0000 USD 1 us-gaap/2024 Geographical= T W;
0001641172-25-009950 20250331 Operating Lease Liability Current 33504.0000 USD 0 us-gaap/2024
0001641172-25-009950 20240331 Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax -34591.0000 USD 1 us-gaap/2024
0001641172-25-009950 20240331 Other Comprehensive Income Loss Net Of Tax USD 1 us-gaap/2024 Equity Components= Common Stock;
0001641172-25-009950 20250331 Preferred Stock Value USD 0 us-gaap/2024
0001641172-25-009950 20250331 Proceeds From Repayments Of Short Term Debt 37909.0000 USD 1 us-gaap/2024
0001641172-25-009950 20240331 Property Plant And Equipment Net -981012.0000 USD 0 us-gaap/2024 Restatement= Revision Of Prior Period Reclassification Adjustment; An adjustment for $792,612 related to expensing the research and development expense was needed related to activity in 2023. The amount was recorded as a reduction to assets and the associated expense was recorded to the statement of operations. An adjustment for a total of $188,400 related to expensing the research and development expense versus being capitalized was needed related for the three months ended March 31, 2024. The amount was recorded as a reduction to assets and the associated expense was rec
0001641172-25-009950 20240331 Research And Development Expense USD 1 us-gaap/2024 Geographical= T W;
0001641172-25-009950 20240331 Research And Development Expense 188400.0000 USD 1 us-gaap/2024 Geographical= U S;
0001641172-25-009950 20240331 Research And Development Expense USD 1 us-gaap/2024 Restatement= Scenario Previously Reported;
0001641172-25-009950 20240331 Revenue From Contract With Customer Excluding Assessed Tax 50697.0000 USD 1 us-gaap/2024 Contract With Customer Sales Channel= Distributors;
0001641172-25-009950 20250331 Revenue From Contract With Customer Excluding Assessed Tax 611885.0000 USD 1 us-gaap/2024 Contract With Customer Sales Channel= Taiwan Government;
0001641172-25-009950 20240331 Selling General And Administrative Expense 1325359.0000 USD 1 us-gaap/2024 Restatement= Restated;
0001641172-25-009950 20240331 Selling General And Administrative Expense 1342863.0000 USD 1 us-gaap/2024 Restatement= Scenario Previously Reported;
0001641172-25-009950 20240331 Shares Outstanding 2021236.0000 shares 0 us-gaap/2024 Equity Components= Common Stock;
0001641172-25-009950 20231231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 4648480.0000 USD 0 us-gaap/2024
0001641172-25-009950 20231231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 54065775.0000 USD 0 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001641172-25-009950 20231231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest -49049994.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings; Restatement= Restatement Adjustment;
0001641172-25-009950 20240331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest -50485493.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings; Restatement= Restated;
0001641172-25-009950 20240331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 3320603.0000 USD 0 us-gaap/2024 Restatement= Restated;
0001641172-25-009950 20250331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest -291089.0000 USD 0 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001641172-25-009950 20240331 Weighted Average Number Of Shares Outstanding Basic 2021237.0000 shares 1 us-gaap/2024
0001641172-25-004833 20241231 Accounts Receivable Net Current 1277635.0000 USD 0 us-gaap/2024
0001641172-25-004833 20241231 Cash And Cash Equivalents At Carrying Value 2629287.0000 USD 0 us-gaap/2024
0001641172-25-004833 20241231 Common Stock Value 28.0000 USD 0 us-gaap/2024
0001641172-25-004833 20231231 Earnings Per Share Basic -2.0700 USD 4 us-gaap/2024
0001641172-25-004833 20241231 Earnings Per Share Diluted -1.8100 USD 4 us-gaap/2024
0001641172-25-004833 20231231 Gain Loss On Investments -180000.0000 USD 4 us-gaap/2024
0001641172-25-004833 20241231 Income Loss From Equity Method Investments USD 4 us-gaap/2024
0001641172-25-004833 20241231 Increase Decrease In Inventories -176395.0000 USD 4 us-gaap/2024
0001641172-25-004833 20241231 Interest Paid Net 15316.0000 USD 4 us-gaap/2024
0001641172-25-004833 20241231 Long Term Debt Current 122007.0000 USD 0 us-gaap/2024
0001641172-25-004833 20231231 Net Cash Provided By Used In Financing Activities 99048.0000 USD 4 us-gaap/2024 Restatement= Revision Of Prior Period Reclassification Adjustment;
0001641172-25-004833 20231231 Net Cash Provided By Used In Financing Activities 924100.0000 USD 4 us-gaap/2024 Restatement= Scenario Previously Reported;
0001641172-25-004833 20231231 Net Income Loss USD 4 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001641172-25-004833 20231231 Operating Expenses 1005269.0000 USD 4 us-gaap/2024 Geographical= T W;
0001641172-25-004833 20231231 Operating Income Loss -4183943.0000 USD 4 us-gaap/2024 Geographical= U S;
0001641172-25-004833 20241231 Operating Income Loss -4070303.0000 USD 4 us-gaap/2024
0001641172-25-004833 20241231 Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax -58792.0000 USD 4 us-gaap/2024
0001641172-25-004833 20231231 Other Comprehensive Income Loss Net Of Tax -775.0000 USD 4 us-gaap/2024
0001641172-25-004833 20241231 Other Comprehensive Income Loss Net Of Tax USD 4 us-gaap/2024 Equity Components= Common Stock;
0001641172-25-004833 20241231 Preferred Stock Par Or Stated Value Per Share 0.0000 USD 0 us-gaap/2024 Class Of Stock= Series B Preferred Stock;
0001641172-25-004833 20231231 Preferred Stock Shares Authorized 12500000.0000 shares 0 us-gaap/2024
0001641172-25-004833 20231231 Preferred Stock Shares Authorized 500.0000 shares 0 us-gaap/2024 Class Of Stock= Series B Preferred Stock;
0001641172-25-004833 20241231 Preferred Stock Shares Authorized 12500000.0000 shares 0 us-gaap/2024 Range= Maximum;
0001641172-25-004833 20231231 Property Plant And Equipment Net 98575.0000 USD 0 us-gaap/2024 Restatement= Restated;
0001641172-25-004833 20241231 Property Plant And Equipment Net 68677.0000 USD 0 us-gaap/2024
0001641172-25-004833 20231231 Retained Earnings Accumulated Deficit -1254101.0000 USD 0 us-gaap/2024 Restatement= Revision Of Prior Period Reclassification Adjustment; Each of the above restatements effected Accumulated Deficit
0001641172-25-004833 20241231 Retained Earnings Accumulated Deficit -53176717.0000 USD 0 us-gaap/2024
0001641172-25-004833 20241231 Revenue From Contract With Customer Excluding Assessed Tax 4675122.0000 USD 4 us-gaap/2024 Contract With Customer Sales Channel= Commercial Enterprises;
0001641172-25-004833 20241231 Revenue From Contract With Customer Excluding Assessed Tax 92625.0000 USD 4 us-gaap/2024 Contract With Customer Sales Channel= Other;
0001641172-25-004833 20221231 Shares Outstanding 1883342.0000 shares 0 us-gaap/2024 Equity Components= Common Stock;
0001641172-25-004833 20231231 Shares Outstanding 2021236.0000 shares 0 us-gaap/2024 Equity Components= Common Stock;
0001641172-25-004833 20211231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 52497045.0000 USD 0 us-gaap/2024 Equity Components= Additional Paid In Capital; Restatement= Restatement Adjustment;
0001641172-25-004833 20211231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 19.0000 USD 0 us-gaap/2024 Equity Components= Common Stock; Restatement= Restatement Adjustment;
0001641172-25-004833 20221231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest -220643.0000 USD 0 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001641172-25-004833 20221231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest -220643.0000 USD 0 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income; Restatement= Restated;
0001641172-25-004833 20221231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 19.0000 USD 0 us-gaap/2024 Equity Components= Common Stock; Restatement= Scenario Previously Reported;
0001641172-25-004833 20241231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest -53176717.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings;
0001641172-25-004833 20240930 Stock Issued During Period Shares New Issues 625000.0000 shares 0 us-gaap/2024
0001641172-25-004833 20241231 Stock Issued During Period Value Issued For Services 90000.0000 USD 4 us-gaap/2024
0001641172-25-004833 20231231 Stock Issued During Period Value Stock Warrants Exercised USD 4 0001641172-25-004833 Equity Components= Accumulated Other Comprehensive Income;
0001641172-25-004833 20241231 Stock Issued During Reverse Split Fractional Shares Value 2.0000 USD 4 0001641172-25-004833 Equity Components= Common Stock;
0001641172-25-004833 20231231 Weighted Average Number Of Diluted Shares Outstanding 1996678.0000 shares 4 us-gaap/2024
0001641172-25-009950 20240331 Accumulated Other Comprehensive Income Loss Net Of Tax -257178.0000 USD 0 us-gaap/2024 Restatement= Scenario Previously Reported;
0001641172-25-009950 20240331 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations 4017034.0000 USD 0 us-gaap/2024
0001641172-25-009950 20240331 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect -851248.0000 USD 1 us-gaap/2024
0001641172-25-009950 20250331 Cost Of Revenue 183628.0000 USD 1 us-gaap/2024 Geographical= U S;
0001641172-25-009950 20241231 Deferred Costs Current 507308.0000 USD 0 us-gaap/2024
0001641172-25-009950 20240331 Earnings Per Share Basic -0.5700 USD 1 us-gaap/2024 Restatement= Scenario Previously Reported;
0001641172-25-009950 20240331 Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest -1258251.0000 USD 1 us-gaap/2024
0001641172-25-009950 20240331 Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest -170896.0000 USD 1 us-gaap/2024 Restatement= Revision Of Prior Period Reclassification Adjustment;
0001641172-25-009950 20240331 Increase Decrease In Deferred Charges USD 1 us-gaap/2024
0001641172-25-009950 20240331 Interest Expense Nonoperating 4285.0000 USD 1 us-gaap/2024
0001641172-25-009950 20241231 Liabilities Current 2297889.0000 USD 0 us-gaap/2024
0001641172-25-009950 20250331 Long Term Debt Current 120294.0000 USD 0 us-gaap/2024
0001641172-25-009950 20241231 Long Term Debt Noncurrent 376188.0000 USD 0 us-gaap/2024
0001641172-25-009950 20250331 Long Term Debt Noncurrent 340831.0000 USD 0 us-gaap/2024
0001641172-25-009950 20240331 Net Income Loss -73721.0000 USD 1 us-gaap/2024 Geographical= T W;
0001641172-25-009950 20250331 Net Income Loss USD 1 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001641172-25-009950 20250331 Operating Income Loss -887015.0000 USD 1 us-gaap/2024 Geographical= U S;
0001641172-25-009950 20241231 Other Assets Noncurrent 84424.0000 USD 0 us-gaap/2024
0001641172-25-009950 20240331 Other Comprehensive Income Loss Net Of Tax -34591.0000 USD 1 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001641172-25-009950 20250331 Other Nonoperating Income Expense 32422.0000 USD 1 us-gaap/2024
0001641172-25-009950 20241231 Preferred Stock Value USD 0 us-gaap/2024
0001641172-25-009950 20240331 Present Value Of Right Of Use Asset And Lease Obligations On New Lease USD 1 0001641172-25-009950
0001641172-25-009950 20250331 Research And Development Expense 33000.0000 USD 1 us-gaap/2024 Geographical= U S;
0001641172-25-009950 20241231 Restricted Cash 29013.0000 USD 0 us-gaap/2024
0001641172-25-009950 20240331 Revenue From Contract With Customer Excluding Assessed Tax USD 1 us-gaap/2024 Contract With Customer Sales Channel= Taiwan Government;
0001641172-25-009950 20250331 Revenue From Contract With Customer Excluding Assessed Tax 178166.0000 USD 1 us-gaap/2024 Contract With Customer Sales Channel= Distributors;
0001641172-25-009950 20250331 Revenue From Contract With Customer Excluding Assessed Tax 1236150.0000 USD 1 us-gaap/2024 Geographical= T W;
0001641172-25-009950 20250331 Revenue From Contract With Customer Excluding Assessed Tax 238426.0000 USD 1 us-gaap/2024 Geographical= U S;
0001641172-25-009950 20240331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 54062085.0000 USD 0 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001641172-25-009950 20240331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 20.0000 USD 0 us-gaap/2024 Equity Components= Common Stock;
0001641172-25-009950 20250331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 28.0000 USD 0 us-gaap/2024 Equity Components= Common Stock;
0001641172-25-009950 20240331 Weighted Average Number Of Diluted Shares Outstanding 2021237.0000 shares 1 us-gaap/2024
0001641172-25-009950 20240331 Weighted Average Number Of Diluted Shares Outstanding 2021237.0000 shares 1 us-gaap/2024 Restatement= Restated;
0001641172-25-009950 20250331 Weighted Average Number Of Diluted Shares Outstanding 2808071.0000 shares 1 us-gaap/2024
0001641172-25-009950 20240331 Weighted Average Number Of Shares Outstanding Basic 2021237.0000 shares 1 us-gaap/2024 Restatement= Restated;
0001641172-25-004833 20231231 Inventory Net 324515.0000 USD 0 us-gaap/2024
0001641172-25-015284 20231231 Accumulated Other Comprehensive Income Loss Net Of Tax -221418.0000 USD 0 us-gaap/2024 Restatement= Restated;
0001641172-25-015284 20231231 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value USD 4 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001641172-25-015284 20241231 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 122600.0000 USD 4 us-gaap/2024
0001641172-25-015284 20241231 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value USD 4 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001641172-25-015284 20241231 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 122600.0000 USD 4 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001641172-25-015284 20241231 Assets 5179516.0000 USD 0 us-gaap/2024
0001641172-25-015284 20231231 Cash And Cash Equivalents At Carrying Value 4754597.0000 USD 0 us-gaap/2024 Restatement= Scenario Previously Reported;
0001641172-25-015284 20221231 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations 7441622.0000 USD 0 us-gaap/2024
0001641172-25-015284 20231231 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect -2573340.0000 USD 4 us-gaap/2024
0001641172-25-015284 20241231 Common Stock Shares Authorized 300000000.0000 shares 0 us-gaap/2024 Range= Maximum;
0001641172-25-015284 20250228 Common Stock Shares Issued 300.0000 shares 0 us-gaap/2024 Subsequent Event Type= Subsequent Event;
0001641172-25-015284 20231231 Deferred Income Tax Effects To Equity Prior Period Adjustment USD 4 0001641172-25-015284 Equity Components= Accumulated Other Comprehensive Income; Restatement= Scenario Previously Reported;
0001641172-25-015284 20231231 Earnings Per Share Basic 0.2000 USD 4 us-gaap/2024 Restatement= Scenario Previously Reported;
0001641172-25-015284 20241231 Earnings Per Share Basic -1.8100 USD 4 us-gaap/2024
0001641172-25-015284 20241231 Gross Profit 1047383.0000 USD 4 us-gaap/2024 Geographical= T W;
0001641172-25-015284 20241231 Increase Decrease In Accounts Receivable 996586.0000 USD 4 us-gaap/2024
0001641172-25-015284 20231231 Increase Decrease In Inventories -199124.0000 USD 4 us-gaap/2024
0001641172-25-015284 20241231 Increase Decrease In Other Accounts Payable 439945.0000 USD 4 us-gaap/2024
0001641172-25-015284 20241231 Interest Expense Nonoperating 26183.0000 USD 4 us-gaap/2024
0001641172-25-015284 20231231 Inventory Net 324515.0000 USD 0 us-gaap/2024
0001641172-25-015284 20241231 Inventory Net 148120.0000 USD 0 us-gaap/2024
0001641172-25-015284 20231231 Liabilities And Stockholders Equity 6306165.0000 USD 0 us-gaap/2024
0001641172-25-015284 20231231 Liabilities Current 1657685.0000 USD 0 us-gaap/2024
0001641172-25-015284 20241231 Liabilities Current 2297889.0000 USD 0 us-gaap/2024
0001641172-25-015284 20231231 Long Term Debt USD 0 us-gaap/2024
0001641172-25-015284 20231231 Net Cash Provided By Used In Financing Activities 685.0000 USD 4 us-gaap/2024 Income Statement Location= Restricted Cash Write Off; Restatement= Revision Of Prior Period Reclassification Adjustment;
0001641172-25-015284 20241231 Net Cash Provided By Used In Financing Activities 2260419.0000 USD 4 us-gaap/2024
0001641172-25-015284 20231231 Net Cash Provided By Used In Operating Activities 180000.0000 USD 4 us-gaap/2024 Income Statement Location= Loss From Joint Venture; Restatement= Revision Of Prior Period Reclassification Adjustment;
0001641172-25-015284 20231231 Net Cash Provided By Used In Operating Activities -792612.0000 USD 4 us-gaap/2024 Restatement= Revision Of Prior Period Reclassification Adjustment;
0001641172-25-015284 20231231 Net Income Loss USD 4 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001641172-25-015284 20241231 Net Income Loss USD 4 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001641172-25-015284 20241231 Net Income Loss USD 4 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001641172-25-015284 20241231 Net Income Loss -3980820.0000 USD 4 us-gaap/2024 Equity Components= Retained Earnings;
0001641172-25-015284 20231231 Other Nonoperating Income Expense -28099.0000 USD 4 us-gaap/2024
0001641172-25-015284 20240930 Proceeds From Issuance Of Common Stock 1683970.0000 USD 0 us-gaap/2024
0001641172-25-015284 20231231 Proceeds From Repayments Of Notes Payable -251498.0000 USD 4 us-gaap/2024
0001641172-25-015284 20231231 Property Plant And Equipment Net 98575.0000 USD 0 us-gaap/2024
0001641172-25-015284 20231231 Restricted Cash 129778.0000 USD 0 us-gaap/2024
0001641172-25-015284 20231231 Retained Earnings Accumulated Deficit -49195897.0000 USD 0 us-gaap/2024
0001641172-25-015284 20231231 Revenue From Contract With Customer Excluding Assessed Tax USD 4 us-gaap/2024 Contract With Customer Sales Channel= Taiwan Government;
0001641172-25-015284 20241231 Revenue From Contract With Customer Excluding Assessed Tax 5592395.0000 USD 4 us-gaap/2024 Product Or Service= Equipment Sales;
0001641172-25-015284 20241231 Selling General And Administrative Expense 5008587.0000 USD 4 us-gaap/2024
0001641172-25-015284 20221231 Shares Outstanding 1883342.0000 shares 0 us-gaap/2024 Equity Components= Common Stock; Restatement= Restated;
0001641172-25-015284 20221231 Shares Outstanding 2021236.0000 shares 0 us-gaap/2024 Equity Components= Common Stock; Restatement= Restatement Adjustment;
0001641172-25-015284 20231231 Shares Outstanding 2021236.0000 shares 0 us-gaap/2024 Equity Components= Common Stock; Restatement= Restated;
0001641172-25-015284 20211231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest USD 0 us-gaap/2024 Equity Components= Noncontrolling Interest; Restatement= Restatement Adjustment;
0001641172-25-015284 20221231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest -99048.0000 USD 0 us-gaap/2024 Equity Components= Noncontrolling Interest; Restatement= Restatement Adjustment;
0001641172-25-015284 20221231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest -45053231.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings;
0001641172-25-015284 20221231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest -44706671.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings; Restatement= Scenario Previously Reported;
0001641172-25-015284 20231231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 4648480.0000 USD 0 us-gaap/2024
0001641172-25-015284 20231231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest USD 0 us-gaap/2024 Equity Components= Noncontrolling Interest; Restatement= Restated;
0001641172-25-015284 20231231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest -49195897.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings; Restatement= Restated;
0001641172-25-015284 20231231 Stock Issued During Period Shares Stock Warrants Exercised 118238.0000 shares 4 0001641172-25-015284 Equity Components= Common Stock;
0001641172-25-015284 20241231 Stock Issued During Period Value Issued For Services USD 4 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001641172-25-015284 20241231 Stock Issued During Period Value New Issues USD 4 us-gaap/2024 Equity Components= Retained Earnings;
0001641172-25-004833 20231231 Share Based Compensation 104600.0000 USD 4 us-gaap/2024
0001641172-25-004833 20250228 Preferred Stock Par Or Stated Value Per Share 0.0000 USD 0 us-gaap/2024 Subsequent Event Type= Subsequent Event;
0001641172-25-004833 20231231 Accounts Payable And Other Accrued Liabilities Current 1308914.0000 USD 0 us-gaap/2024
0001641172-25-004833 20231231 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value USD 4 us-gaap/2024 Equity Components= Retained Earnings;
0001641172-25-004833 20241231 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value USD 4 us-gaap/2024 Equity Components= Retained Earnings;
0001641172-25-004833 20231231 Adjustments To Additional Paid In Capital Warrant Issued USD 4 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001641172-25-004833 20231231 Assets 6306165.0000 USD 0 us-gaap/2024
0001641172-25-004833 20231231 Cash And Cash Equivalents At Carrying Value -16093.0000 USD 0 us-gaap/2024 Restatement= Revision Of Prior Period Reclassification Adjustment;
0001641172-25-004833 20231231 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect -2573340.0000 USD 4 us-gaap/2024
0001641172-25-004833 20231231 Common Stock Shares Outstanding 2021236.0000 shares 0 us-gaap/2024
0001641172-25-004833 20231231 Common Stock Warrants Issued For Services 2700.0000 USD 4 0001641172-25-004833
0001641172-25-004833 20231231 Cost Of Revenue 5428261.0000 USD 4 us-gaap/2024
0001641172-25-004833 20241231 Cost Of Revenue 615010.0000 USD 4 us-gaap/2024 Geographical= U S;
0001641172-25-004833 20231231 Earnings Per Share Diluted 0.2000 USD 4 us-gaap/2024 Restatement= Scenario Previously Reported;
0001641172-25-004833 20231231 Gain Loss On Investments 180000.0000 USD 4 us-gaap/2024 Restatement= Revision Of Prior Period Reclassification Adjustment;
0001641172-25-004833 20231231 Gross Profit 1148336.0000 USD 4 us-gaap/2024 Geographical= T W;
0001641172-25-004833 20241231 Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest -3948435.0000 USD 4 us-gaap/2024
0001641172-25-004833 20231231 Income Taxes Paid Net 28779.0000 USD 4 us-gaap/2024
0001641172-25-004833 20241231 Income Taxes Paid Net 38544.0000 USD 4 us-gaap/2024
0001641172-25-004833 20231231 Income Tax Expense Benefit 18308.0000 USD 4 us-gaap/2024
0001641172-25-004833 20231231 Increase Decrease In Other Accounts Payable -522460.0000 USD 4 us-gaap/2024 Restatement= Scenario Previously Reported;
0001641172-25-004833 20231231 Interest Expense Nonoperating 7254.0000 USD 4 us-gaap/2024
0001641172-25-004833 20241231 Long Term Debt 498195.0000 USD 0 us-gaap/2024 Related Party Transactions By Related Party= Chang Hwa Bank;
0001641172-25-004833 20231231 Net Cash Provided By Used In Operating Activities -3333360.0000 USD 4 us-gaap/2024
0001641172-25-004833 20231231 Net Income Loss -4142666.0000 USD 4 us-gaap/2024 Restatement= Restated;
0001641172-25-004833 20231231 Net Income Loss -907542.0000 USD 4 us-gaap/2024 Restatement= Revision Of Prior Period Reclassification Adjustment;
0001641172-25-004833 20241231 Net Income Loss -3980820.0000 USD 4 us-gaap/2024
0001641172-25-004833 20241231 Operating Income Loss 32274.0000 USD 4 us-gaap/2024 Geographical= T W;
0001641172-25-004833 20241231 Other Assets Noncurrent 84424.0000 USD 0 us-gaap/2024
0001641172-25-004833 20231231 Other Comprehensive Income Loss Net Of Tax -775.0000 USD 4 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001641172-25-004833 20231231 Payments To Acquire Equity Securities Fv Ni 180000.0000 USD 4 us-gaap/2024
0001641172-25-004833 20231231 Payments To Acquire Property Plant And Equipment 85593.0000 USD 4 us-gaap/2024
0001641172-25-004833 20241231 Preferred Stock Shares Authorized 12500000.0000 shares 0 us-gaap/2024
0001641172-25-004833 20241231 Preferred Stock Shares Authorized 1250000.0000 shares 0 us-gaap/2024 Class Of Stock= Series A Preferred Stock;
0001641172-25-004833 20231231 Preferred Stock Value USD 0 us-gaap/2024 Class Of Stock= Series B Preferred Stock;
0001641172-25-004833 20241231 Preferred Stock Value USD 0 us-gaap/2024 Class Of Stock= Series B Preferred Stock;
0001641172-25-004833 20231231 Proceeds From Issuance Of Common Stock 1322885.0000 USD 4 us-gaap/2024
0001641172-25-004833 20231231 Property Plant And Equipment Net -792612.0000 USD 0 us-gaap/2024 Restatement= Revision Of Prior Period Reclassification Adjustment; 2023 capitalized software expensed to Research and Development
0001641172-25-004833 20231231 Research And Development Expense 797112.0000 USD 4 us-gaap/2024
0001641172-25-004833 20231231 Research And Development Expense 797112.0000 USD 4 us-gaap/2024 Restatement= Restated;
0001641172-25-004833 20241231 Research And Development Expense 363350.0000 USD 4 us-gaap/2024 Geographical= U S;
0001641172-25-004833 20241231 Restricted Cash 29013.0000 USD 0 us-gaap/2024
0001641172-25-004833 20231231 Revenue From Contract With Customer Excluding Assessed Tax 852136.0000 USD 4 us-gaap/2024 Geographical= U S;
0001641172-25-004833 20241231 Short Term Borrowings 152509.0000 USD 0 us-gaap/2024 Related Party Transactions By Related Party= Chang Hwa Bank;
0001641172-25-004833 20241231 Short Term Borrowings 91505.0000 USD 0 us-gaap/2024 Related Party Transactions By Related Party= Hua Nam Bank;
0001641172-25-004833 20211231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest -44706671.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings; Restatement= Restatement Adjustment;
0001641172-25-004833 20211231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 7569750.0000 USD 0 us-gaap/2024 Restatement= Restatement Adjustment;
0001641172-25-004833 20221231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 19.0000 USD 0 us-gaap/2024 Equity Components= Common Stock;
0001641172-25-004833 20221231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest -45053231.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings;
0001641172-25-004833 20231231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 4648480.0000 USD 0 us-gaap/2024 Restatement= Restated;
0001641172-25-004833 20241231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest -280209.0000 USD 0 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001641172-25-004833 20231231 Stock Issued During Period Shares Issued For Services 19656.0000 shares 4 us-gaap/2024
0001641172-25-004833 20241231 Stock Issued During Period Shares New Issues 625000.0000 shares 4 us-gaap/2024 Equity Components= Common Stock;
0001641172-25-004833 20241231 Stock Issued During Period Value Issued For Services 90000.0000 USD 4 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001641172-25-004833 20241231 Stock Issued During Period Value New Issues USD 4 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001641172-25-004833 20231231 Stock Issued During Period Value Stock Warrants Exercised 1.0000 USD 4 0001641172-25-004833 Equity Components= Common Stock;
0001641172-25-004833 20241231 Stock Issued During Reverse Split Fractional Shares Value USD 4 0001641172-25-004833 Equity Components= Retained Earnings;
0001641172-25-009950 20250331 Accumulated Other Comprehensive Income Loss Net Of Tax -291089.0000 USD 0 us-gaap/2024
0001641172-25-009950 20240331 Adjustments To Additional Paid In Capital Other USD 1 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001641172-25-009950 20240331 Adjustments To Additional Paid In Capital Other USD 1 us-gaap/2024 Equity Components= Common Stock;
0001641172-25-009950 20241231 Common Stock Shares Issued 2808071.0000 shares 0 us-gaap/2024
0001641172-25-009950 20240331 Cost Of Revenue 103481.0000 USD 1 us-gaap/2024 Geographical= T W;
0001641172-25-009950 20250331 Earnings Per Share Diluted -0.2800 USD 1 us-gaap/2024
0001641172-25-009950 20240331 Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations -83384.0000 USD 1 us-gaap/2024
0001641172-25-009950 20240331 Gross Profit 23302.0000 USD 1 us-gaap/2024 Geographical= U S;
0001641172-25-009950 20250331 Gross Profit 288211.0000 USD 1 us-gaap/2024
0001641172-25-009950 20250331 Gross Profit 54798.0000 USD 1 us-gaap/2024 Geographical= U S;
0001641172-25-009950 20240331 Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest -1258252.0000 USD 1 us-gaap/2024 Restatement= Restated;
0001641172-25-009950 20250331 Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest -847874.0000 USD 1 us-gaap/2024 Geographical= U S;
0001641172-25-009950 20240331 Income Tax Expense Benefit 31345.0000 USD 1 us-gaap/2024
0001641172-25-009950 20240331 Income Tax Expense Benefit 31345.0000 USD 1 us-gaap/2024 Geographical= T W;
0001641172-25-009950 20250331 Income Tax Expense Benefit USD 1 us-gaap/2024
0001641172-25-009950 20250331 Increase Decrease In Other Accounts Payable -29010.0000 USD 1 us-gaap/2024
0001641172-25-009950 20240331 Interest Paid Net 4285.0000 USD 1 us-gaap/2024
0001641172-25-009950 20250331 Interest Paid Net 6063.0000 USD 1 us-gaap/2024
0001641172-25-009950 20241231 Inventory Net 148120.0000 USD 0 us-gaap/2024
0001641172-25-009950 20240331 Net Cash Provided By Used In Operating Activities -1293473.0000 USD 1 us-gaap/2024 Restatement= Restated;
0001641172-25-009950 20240331 Net Income Loss -1215875.0000 USD 1 us-gaap/2024 Geographical= U S;
0001641172-25-009950 20250331 Net Income Loss -793672.0000 USD 1 us-gaap/2024
0001641172-25-009950 20240331 Operating Expenses 1306054.0000 USD 1 us-gaap/2024 Geographical= U S;
0001641172-25-009950 20240331 Operating Expenses 170896.0000 USD 1 us-gaap/2024 Restatement= Revision Of Prior Period Reclassification Adjustment; An adjustment for $180,000 for the year ended December 31, 2023 to expense its investment in Iveda Phils JV originally recorded as a consolidation ($7,002 net loss for the three months ended March 31, 2024) but we have determined this investment should have been recorded as the equity method. This effected Cash, Accounts and Other Payables, Joint Venture Non-Controlled Equity Portion, Accumulated Other Comprehensive Income (Loss) and accumulated deficit.
0001641172-25-009950 20240331 Operating Income Loss -49127.0000 USD 1 us-gaap/2024 Geographical= T W;
0001641172-25-009950 20241231 Operating Lease Liability Noncurrent USD 0 us-gaap/2024
0001641172-25-009950 20250331 Other Assets Current 296799.0000 USD 0 us-gaap/2024
0001641172-25-009950 20240331 Other Comprehensive Income Loss Net Of Tax -34591.0000 USD 1 us-gaap/2024
0001641172-25-009950 20240331 Other Comprehensive Income Loss Net Of Tax USD 1 us-gaap/2024 Equity Components= Retained Earnings;
0001641172-25-009950 20250331 Other Comprehensive Income Loss Net Of Tax USD 1 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001641172-25-009950 20250331 Proceeds From Issuance Of Common Stock USD 1 us-gaap/2024
0001641172-25-009950 20250331 Property Plant And Equipment Net 64597.0000 USD 0 us-gaap/2024
0001641172-25-009950 20240331 Research And Development Expense 188400.0000 USD 1 us-gaap/2024 Restatement= Restated;
0001641172-25-009950 20250331 Restricted Cash 28606.0000 USD 0 us-gaap/2024 Related Party Transactions By Related Party= Shanghai Bank;
0001641172-25-009950 20240331 Revenue From Contract With Customer Excluding Assessed Tax 263439.0000 USD 1 us-gaap/2024 Contract With Customer Sales Channel= Commercial Enterprises;
0001641172-25-009950 20250331 Revenue From Contract With Customer Excluding Assessed Tax USD 1 us-gaap/2024 Contract With Customer Sales Channel= Other;
0001641172-25-009950 20240331 Selling General And Administrative Expense -17504.0000 USD 1 us-gaap/2024 Restatement= Revision Of Prior Period Reclassification Adjustment;
0001641172-25-009950 20241231 Short Term Borrowings 91505.0000 USD 0 us-gaap/2024 Related Party Transactions By Related Party= Hua Nam Bank;
0001641172-25-009950 20250331 Short Term Borrowings 224347.0000 USD 0 us-gaap/2024 Related Party Transactions By Related Party= Shanghai Bank;
0001641172-25-009950 20231231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 4645074.0000 USD 0 us-gaap/2024 Restatement= Restatement Adjustment;
0001641172-25-009950 20240331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest -256009.0000 USD 0 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001641172-25-004833 20241231 Selling General And Administrative Expense 5008587.0000 USD 4 us-gaap/2024
0001641172-25-004833 20221231 Shares Outstanding 1883342.0000 shares 0 us-gaap/2024 Equity Components= Common Stock; Restatement= Restated;
0001641172-25-004833 20211231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest USD 0 us-gaap/2024 Equity Components= Noncontrolling Interest; Restatement= Restatement Adjustment;
0001641172-25-004833 20221231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 52497045.0000 USD 0 us-gaap/2024 Equity Components= Additional Paid In Capital; Restatement= Restated;
0001641172-25-004833 20221231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest USD 0 us-gaap/2024 Equity Components= Noncontrolling Interest; Restatement= Restated;
0001641172-25-004833 20231231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest USD 0 us-gaap/2024 Equity Components= Noncontrolling Interest; Restatement= Restated;
0001641172-25-004833 20231231 Stock Issued During Period Shares Issued For Services 19656.0000 shares 4 us-gaap/2024 Equity Components= Common Stock;
0001641172-25-004833 20241231 Stock Issued During Period Value Issued For Services USD 4 us-gaap/2024 Equity Components= Retained Earnings;
0001641172-25-004833 20241231 Stock Issued During Period Value New Issues 1683970.0000 USD 4 us-gaap/2024
0001641172-25-004833 20241231 Stock Issued During Period Value New Issues 1683964.0000 USD 4 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001641172-25-004833 20241231 Stock Issued During Period Value New Issues USD 4 us-gaap/2024 Equity Components= Retained Earnings;
0001641172-25-004833 20241231 Stock Issued During Reverse Split Fractional Shares Value USD 4 0001641172-25-004833 Equity Components= Accumulated Other Comprehensive Income;
0001641172-25-004833 20241231 Inventory Net 148120.0000 USD 0 us-gaap/2024
0001641172-25-004833 20231231 Liabilities And Stockholders Equity 6306165.0000 USD 0 us-gaap/2024
0001641172-25-004833 20241231 Liabilities Current 2297889.0000 USD 0 us-gaap/2024
0001641172-25-004833 20231231 Long Term Debt USD 0 us-gaap/2024
0001641172-25-004833 20241231 Accounts Payable And Other Accrued Liabilities Current 1748857.0000 USD 0 us-gaap/2024
0001641172-25-004833 20231231 Accumulated Other Comprehensive Income Loss Net Of Tax -221418.0000 USD 0 us-gaap/2024 Restatement= Restated;
0001641172-25-004833 20231231 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 104600.0000 USD 4 us-gaap/2024
0001641172-25-004833 20231231 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value USD 4 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001641172-25-004833 20231231 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 104600.0000 USD 4 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001641172-25-004833 20241231 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 122600.0000 USD 4 us-gaap/2024
0001641172-25-004833 20241231 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value USD 4 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001641172-25-004833 20231231 Adjustments To Additional Paid In Capital Warrant Issued USD 4 us-gaap/2024 Equity Components= Common Stock;
0001641172-25-004833 20221231 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations 7441622.0000 USD 0 us-gaap/2024
0001641172-25-004833 20231231 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect -15841.0000 USD 4 us-gaap/2024 Restatement= Revision Of Prior Period Reclassification Adjustment;
0001641172-25-004833 20241231 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect -2209982.0000 USD 4 us-gaap/2024
0001641172-25-004833 20231231 Common Stock Issued For Services 138546.0000 USD 4 0001641172-25-004833
0001641172-25-004833 20250228 Common Stock Shares Issued 300.0000 shares 0 us-gaap/2024 Subsequent Event Type= Subsequent Event;
0001641172-25-004833 20231231 Cost Of Revenue 932868.0000 USD 4 us-gaap/2024 Geographical= U S;
0001641172-25-004833 20241231 Cost Of Revenue 4719005.0000 USD 4 us-gaap/2024
0001641172-25-004833 20241231 Deferred Costs Current 507308.0000 USD 0 us-gaap/2024
0001641172-25-004833 20231231 Deferred Income Tax Effects To Equity Prior Period Adjustment 346560.0000 USD 4 0001641172-25-004833 Equity Components= Retained Earnings; Restatement= Scenario Previously Reported;
0001641172-25-004833 20231231 Earnings Per Share Basic 2.0700 USD 4 us-gaap/2024 Restatement= Restated; Restated per share amount reflects a reverse stock split of the outstanding shares of our Common Stock at a ratio of 1-for-8 effected on September 17, 2024.
0001641172-25-004833 20241231 Earnings Per Share Basic -1.8100 USD 4 us-gaap/2024
0001641172-25-004833 20231231 Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations 1780.0000 USD 4 us-gaap/2024 Restatement= Restated;
0001641172-25-004833 20241231 Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations -48045.0000 USD 4 us-gaap/2024
0001641172-25-004833 20250228 Stock Issued During Period Value Issued For Services 5082431.0000 USD 0 us-gaap/2024 Subsequent Event Type= Subsequent Event; Type Of Arrangement= At The Market Offering Agreement;
0001641172-25-004833 20231231 Increase Decrease In Inventories -199124.0000 USD 4 us-gaap/2024
0001641172-25-004833 20231231 Increase Decrease In Other Current Assets 66995.0000 USD 4 us-gaap/2024
0001641172-25-004833 20241231 Increase Decrease In Other Current Assets -528.0000 USD 4 us-gaap/2024
0001641172-25-004833 20231231 Long Term Debt Current USD 0 us-gaap/2024
0001641172-25-004833 20231231 Net Cash Provided By Used In Financing Activities 129778.0000 USD 4 us-gaap/2024 Income Statement Location= Additional Restricted Cash; Restatement= Revision Of Prior Period Reclassification Adjustment; Added Restricted Cash to Cash and Cash Equivalents
0001641172-25-004833 20231231 Net Cash Provided By Used In Financing Activities 685.0000 USD 4 us-gaap/2024 Income Statement Location= Restricted Cash Write Off; Restatement= Revision Of Prior Period Reclassification Adjustment;
0001641172-25-004833 20231231 Net Cash Provided By Used In Investing Activities -792612.0000 USD 4 us-gaap/2024 Restatement= Revision Of Prior Period Reclassification Adjustment;
0001641172-25-004833 20241231 Net Cash Provided By Used In Investing Activities -2608.0000 USD 4 us-gaap/2024
0001641172-25-004833 20231231 Net Cash Provided By Used In Operating Activities 180000.0000 USD 4 us-gaap/2024 Income Statement Location= Loss From Joint Venture; Restatement= Revision Of Prior Period Reclassification Adjustment;
0001641172-25-004833 20231231 Net Cash Provided By Used In Operating Activities -792612.0000 USD 4 us-gaap/2024 Restatement= Revision Of Prior Period Reclassification Adjustment;
0001641172-25-004833 20231231 Operating Income Loss 180000.0000 USD 4 us-gaap/2024 Restatement= Restated;
0001641172-25-004833 20241231 Operating Income Loss -4102577.0000 USD 4 us-gaap/2024 Geographical= U S;
0001641172-25-004833 20231231 Other Nonoperating Income Expense -28099.0000 USD 4 us-gaap/2024
0001641172-25-004833 20241231 Preferred Stock Shares Issued 0.0000 shares 0 us-gaap/2024 Class Of Stock= Series B Preferred Stock;
0001641172-25-004833 20240930 Proceeds From Issuance Of Common Stock 1683970.0000 USD 0 us-gaap/2024
0001641172-25-004833 20231231 Proceeds From Repayments Of Notes Payable -251498.0000 USD 4 us-gaap/2024
0001641172-25-004833 20231231 Research And Development Expense 797112.0000 USD 4 us-gaap/2024 Geographical= U S;
0001641172-25-004833 20241231 Research And Development Expense 363350.0000 USD 4 us-gaap/2024
0001641172-25-004833 20231231 Revenue From Contract With Customer Excluding Assessed Tax 6104478.0000 USD 4 us-gaap/2024 Contract With Customer Sales Channel= Commercial Enterprises;
0001641172-25-004833 20231231 Revenue From Contract With Customer Excluding Assessed Tax 148311.0000 USD 4 us-gaap/2024 Contract With Customer Sales Channel= Other;
0001641172-25-004833 20231231 Revenue From Contract With Customer Excluding Assessed Tax 5643729.0000 USD 4 us-gaap/2024 Geographical= T W;
0001641172-25-004833 20241231 Revenue From Contract With Customer Excluding Assessed Tax 319767.0000 USD 4 us-gaap/2024 Contract With Customer Sales Channel= Taiwan Government;
0001641172-25-009950 20240331 Accumulated Other Comprehensive Income Loss Net Of Tax -1169.0000 USD 0 us-gaap/2024 Restatement= Revision Of Prior Period Reclassification Adjustment;
0001641172-25-004833 20241231 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 122600.0000 USD 4 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001641172-25-004833 20231231 Adjustments To Additional Paid In Capital Warrant Issued 2700.0000 USD 4 us-gaap/2024
0001641172-25-004833 20231231 Cash And Cash Equivalents At Carrying Value 4738504.0000 USD 0 us-gaap/2024
0001641172-25-004833 20231231 Cash And Cash Equivalents At Carrying Value 4738504.0000 USD 0 us-gaap/2024 Restatement= Restated;
0001641172-25-004833 20231231 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect -2573540.0000 USD 4 us-gaap/2024 Restatement= Restated;
0001641172-25-004833 20241231 Common Stock Issued For Services 90000.0000 USD 4 0001641172-25-004833
0001641172-25-004833 20241231 Common Stock Par Or Stated Value Per Share 0.0000 USD 0 us-gaap/2024
0001641172-25-004833 20250228 Common Stock Par Or Stated Value Per Share 0.0000 USD 0 us-gaap/2024 Subsequent Event Type= Subsequent Event;
0001641172-25-004833 20250228 Common Stock Par Or Stated Value Per Share 0.0000 USD 0 us-gaap/2024 Subsequent Event Type= Subsequent Event; Type Of Arrangement= At The Market Offering Agreement;
0001641172-25-004833 20241231 Common Stock Shares Authorized 300000000.0000 shares 0 us-gaap/2024 Range= Maximum;
0001641172-25-004833 20231231 Common Stock Shares Issued 2021236.0000 shares 0 us-gaap/2024
0001641172-25-004833 20231231 Deferred Income Tax Effects To Equity Prior Period Adjustment USD 4 0001641172-25-004833 Equity Components= Accumulated Other Comprehensive Income; Restatement= Scenario Previously Reported;
0001641172-25-004833 20231231 Deferred Income Tax Effects To Equity Prior Period Adjustment USD 4 0001641172-25-004833 Equity Components= Common Stock; Restatement= Scenario Previously Reported;
0001641172-25-004833 20231231 Earnings Per Share Basic 0.2000 USD 4 us-gaap/2024 Restatement= Scenario Previously Reported;
0001641172-25-004833 20231231 Increase Decrease In Other Accounts Payable -1173.0000 USD 4 us-gaap/2024 Income Statement Location= Increase Decrease In Accounts And Other Payable; Restatement= Revision Of Prior Period Reclassification Adjustment;
0001641172-25-004833 20231231 Increase Decrease In Other Accounts Payable -1173.0000 USD 4 us-gaap/2024 Restatement= Revision Of Prior Period Reclassification Adjustment; An adjustment for $180,000 to expense its investment in Iveda Phils JV originally recorded as a consolidation but we have determined this investment should have been recorded as the equity method. The net loss effect is $180,000 less the $65,070 loss recorded in 2023 in consolidation. Net $114,930 additional loss recorded in 2023.
0001641172-25-004833 20231231 Increase Decrease In Other Noncurrent Assets 175592.0000 USD 4 us-gaap/2024
0001641172-25-004833 20231231 Interest Paid Net 9793.0000 USD 4 us-gaap/2024
0001641172-25-004833 20231231 Net Cash Provided By Used In Financing Activities 1023833.0000 USD 4 us-gaap/2024 Income Statement Location= Restricted Cash Write Off; Restatement= Restated;
0001641172-25-004833 20241231 Net Cash Provided By Used In Financing Activities 2260419.0000 USD 4 us-gaap/2024
0001641172-25-004833 20231231 Net Cash Provided By Used In Investing Activities -85593.0000 USD 4 us-gaap/2024 Restatement= Restated;
0001641172-25-004833 20231231 Net Income Loss USD 4 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001641172-25-004833 20241231 Net Income Loss USD 4 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001641172-25-004833 20241231 Operating Expenses 5371937.0000 USD 4 us-gaap/2024
0001641172-25-004833 20231231 Operating Income Loss -4040875.0000 USD 4 us-gaap/2024
0001641172-25-004833 20241231 Other Comprehensive Income Loss Net Of Tax -58791.0000 USD 4 us-gaap/2024
0001641172-25-004833 20241231 Other Comprehensive Income Loss Net Of Tax USD 4 us-gaap/2024 Equity Components= Retained Earnings;
0001641172-25-004833 20241231 Other Nonoperating Income Expense 34323.0000 USD 4 us-gaap/2024
0001641172-25-004833 20231231 Payments To Acquire Property Plant And Equipment 85593.0000 USD 4 us-gaap/2024 Restatement= Restated;
0001641172-25-004833 20231231 Preferred Stock Par Or Stated Value Per Share 0.0000 USD 0 us-gaap/2024
0001641172-25-004833 20231231 Preferred Stock Par Or Stated Value Per Share 0.0000 USD 0 us-gaap/2024 Class Of Stock= Series B Preferred Stock;
0001641172-25-004833 20241231 Preferred Stock Shares Authorized 500.0000 shares 0 us-gaap/2024 Class Of Stock= Series B Preferred Stock;
0001641172-25-004833 20231231 Property Plant And Equipment Net 1308914.0000 USD 0 us-gaap/2024 Balance Sheet Location= Accounts Payable And Accrued Liabilities; Restatement= Restated;
0001641172-25-004833 20231231 Property Plant And Equipment Net 891187.0000 USD 0 us-gaap/2024 Restatement= Scenario Previously Reported;
0001641172-25-004833 20231231 Retained Earnings Accumulated Deficit -49195897.0000 USD 0 us-gaap/2024
0001641172-25-004833 20231231 Retained Earnings Accumulated Deficit -49195897.0000 USD 0 us-gaap/2024 Restatement= Restated;
0001641172-25-004833 20231231 Revenue From Contract With Customer Excluding Assessed Tax 6052298.0000 USD 4 us-gaap/2024 Product Or Service= Equipment Sales;
0001641172-25-004833 20231231 Revenue From Contract With Customer Excluding Assessed Tax 443567.0000 USD 4 us-gaap/2024 Product Or Service= Service Revenue;
0001641172-25-004833 20241231 Revenue From Contract With Customer Excluding Assessed Tax 428244.0000 USD 4 us-gaap/2024 Product Or Service= Service Revenue;
0001641172-25-004833 20231231 Share Based Compensation 104600.0000 USD 4 us-gaap/2024 Geographical= U S;
0001641172-25-004833 20221231 Shares Outstanding 1883342.0000 shares 0 us-gaap/2024 Equity Components= Common Stock; Restatement= Scenario Previously Reported;
0001641172-25-004833 20231231 Short Term Borrowings 348771.0000 USD 0 us-gaap/2024
0001641172-25-004833 20241231 Short Term Borrowings 183011.0000 USD 0 us-gaap/2024 Related Party Transactions By Related Party= Shanghai Bank;
0001641172-25-004833 20221231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest -222380.0000 USD 0 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income; Restatement= Restatement Adjustment;
0001641172-25-004833 20221231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 52497045.0000 USD 0 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001641172-25-004833 20221231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 20.0000 USD 0 us-gaap/2024 Equity Components= Common Stock; Restatement= Restatement Adjustment;
0001641172-25-004833 20221231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest -99048.0000 USD 0 us-gaap/2024 Equity Components= Noncontrolling Interest; Restatement= Restatement Adjustment;
0001641172-25-004833 20231231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 20.0000 USD 0 us-gaap/2024 Equity Components= Common Stock;
0001641172-25-004833 20231231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest -49195897.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings;
0001641172-25-004833 20241231 Stock Issued During Period Shares Issued For Services 12500.0000 shares 4 us-gaap/2024
0001641172-25-004833 20231231 Stock Issued During Period Shares Stock Warrants Exercised 118238.0000 shares 4 0001641172-25-004833 Equity Components= Common Stock;
0001641172-25-004833 20241231 Stock Issued During Reverse Split Fractional Shares 149335.0000 shares 4 0001641172-25-004833 Equity Components= Common Stock;
0001641172-25-004833 20241231 Stock Issued During Reverse Split Fractional Shares Value USD 4 0001641172-25-004833
0001641172-25-004833 20231231 Weighted Average Number Of Shares Outstanding Basic 1996678.0000 shares 4 us-gaap/2024
0001641172-25-015284 20231231 Revenue From Contract With Customer Excluding Assessed Tax 6052298.0000 USD 4 us-gaap/2024 Product Or Service= Equipment Sales;
0001641172-25-015284 20231231 Accumulated Other Comprehensive Income Loss Net Of Tax -221418.0000 USD 0 us-gaap/2024
0001641172-25-015284 20231231 Adjustments To Additional Paid In Capital Warrant Issued 2700.0000 USD 4 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001641172-25-015284 20231231 Assets 6306165.0000 USD 0 us-gaap/2024
0001641172-25-015284 20231231 Cash And Cash Equivalents At Carrying Value 4738504.0000 USD 0 us-gaap/2024 Restatement= Restated;
0001641172-25-015284 20241231 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect -2209982.0000 USD 4 us-gaap/2024
0001641172-25-015284 20250228 Common Stock Par Or Stated Value Per Share 0.0000 USD 0 us-gaap/2024 Subsequent Event Type= Subsequent Event;
0001641172-25-015284 20231231 Cost Of Revenue 5428261.0000 USD 4 us-gaap/2024
0001641172-25-015284 20231231 Cost Of Revenue 932868.0000 USD 4 us-gaap/2024 Geographical= U S;
0001641172-25-015284 20241231 Cost Of Revenue 615010.0000 USD 4 us-gaap/2024 Geographical= U S;
0001641172-25-015284 20241231 Deferred Costs Current 507308.0000 USD 0 us-gaap/2024
0001641172-25-015284 20231231 Earnings Per Share Diluted 0.2000 USD 4 us-gaap/2024 Restatement= Scenario Previously Reported;
0001641172-25-015284 20231231 Gain Loss On Investments -180000.0000 USD 4 us-gaap/2024
0001641172-25-015284 20231231 Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest 144037.0000 USD 4 us-gaap/2024 Geographical= T W;
0001641172-25-015284 20231231 Income Taxes Paid Net 28779.0000 USD 4 us-gaap/2024
0001641172-25-015284 20231231 Increase Decrease In Deferred Charges USD 4 us-gaap/2024
0001641172-25-015284 20231231 Increase Decrease In Other Accounts Payable -1173.0000 USD 4 us-gaap/2024 Income Statement Location= Increase Decrease In Accounts And Other Payable; Restatement= Revision Of Prior Period Reclassification Adjustment;
0001641172-25-015284 20231231 Increase Decrease In Other Current Assets 66995.0000 USD 4 us-gaap/2024
0001641172-25-015284 20231231 Increase Decrease In Other Noncurrent Assets 175592.0000 USD 4 us-gaap/2024
0001641172-25-015284 20231231 Net Cash Provided By Used In Financing Activities 1023833.0000 USD 4 us-gaap/2024 Income Statement Location= Restricted Cash Write Off; Restatement= Restated;
0001641172-25-015284 20231231 Net Cash Provided By Used In Investing Activities -85593.0000 USD 4 us-gaap/2024 Restatement= Restated;
0001641172-25-015284 20241231 Nonoperating Income Expense 121868.0000 USD 4 us-gaap/2024
0001641172-25-015284 20241231 Other Assets Noncurrent 84424.0000 USD 0 us-gaap/2024
0001641172-25-015284 20231231 Other Comprehensive Income Loss Net Of Tax -775.0000 USD 4 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001641172-25-015284 20241231 Other Nonoperating Income Expense 34323.0000 USD 4 us-gaap/2024
0001641172-25-015284 20231231 Preferred Stock Par Or Stated Value Per Share 0.0000 USD 0 us-gaap/2024 Class Of Stock= Series B Preferred Stock;
0001641172-25-015284 20231231 Preferred Stock Shares Authorized 12500000.0000 shares 0 us-gaap/2024
0001641172-25-015284 20231231 Proceeds From Issuance Of Common Stock 1322885.0000 USD 4 us-gaap/2024
0001641172-25-015284 20231231 Property Plant And Equipment Net -792612.0000 USD 0 us-gaap/2024 Restatement= Revision Of Prior Period Reclassification Adjustment; 2023 capitalized software expensed to Research and Development
0001641172-25-015284 20231231 Research And Development Expense 797112.0000 USD 4 us-gaap/2024 Geographical= U S;
0001641172-25-015284 20231231 Research And Development Expense 4500.0000 USD 4 us-gaap/2024 Restatement= Scenario Previously Reported;
0001641172-25-015284 20241231 Restricted Cash 29013.0000 USD 0 us-gaap/2024
0001641172-25-015284 20231231 Retained Earnings Accumulated Deficit -49195897.0000 USD 0 us-gaap/2024 Restatement= Restated;
0001641172-25-015284 20231231 Revenue From Contract With Customer Excluding Assessed Tax 443567.0000 USD 4 us-gaap/2024 Product Or Service= Service Revenue;
0001641172-25-015284 20241231 Revenue From Contract With Customer Excluding Assessed Tax USD 4 us-gaap/2024 Product Or Service= Other Revenue;
0001641172-25-015284 20241231 Revenue From Contract With Customer Excluding Assessed Tax 428244.0000 USD 4 us-gaap/2024 Product Or Service= Service Revenue;
0001641172-25-015284 20231231 Share Based Compensation 104600.0000 USD 4 us-gaap/2024
0001641172-25-015284 20231231 Share Based Compensation 104600.0000 USD 4 us-gaap/2024 Geographical= U S;
0001641172-25-015284 20221231 Shares Outstanding 1883342.0000 shares 0 us-gaap/2024 Equity Components= Common Stock; Restatement= Scenario Previously Reported;
0001641172-25-015284 20231231 Short Term Borrowings 348771.0000 USD 0 us-gaap/2024
0001641172-25-015284 20221231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 52497045.0000 USD 0 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001641172-25-015284 20221231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 20.0000 USD 0 us-gaap/2024 Equity Components= Common Stock; Restatement= Restatement Adjustment;
0001641172-25-015284 20221231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest USD 0 us-gaap/2024 Equity Components= Noncontrolling Interest; Restatement= Restated;
0001641172-25-015284 20231231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest -221418.0000 USD 0 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001641172-25-015284 20231231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest -221418.0000 USD 0 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income; Restatement= Restated;
0001641172-25-015284 20231231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 20.0000 USD 0 us-gaap/2024 Equity Components= Common Stock;
0001641172-25-015284 20231231 Stock Issued During Period Shares Stock Warrants Exercised 118238.0000 shares 4 0001641172-25-015284
0001641172-25-015284 20241231 Stock Issued During Period Value New Issues 1683964.0000 USD 4 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001641172-25-015284 20231231 Stock Issued During Period Value Stock Warrants Exercised 1322884.0000 USD 4 0001641172-25-015284 Equity Components= Additional Paid In Capital;
0001641172-25-015284 20241231 Stock Issued During Reverse Split Fractional Shares Value USD 4 0001641172-25-015284 Equity Components= Accumulated Other Comprehensive Income;
0001641172-25-015284 20231231 Weighted Average Number Of Shares Outstanding Basic 1996678.0000 shares 4 us-gaap/2024
0001641172-25-004833 20231231 Accounts Payable And Other Accrued Liabilities Current 200000.0000 USD 0 us-gaap/2024 Restatement= Revision Of Prior Period Reclassification Adjustment; The intercompany amount due to Iveda Taiwan was understated by $200,000 related to a payment made on behalf of Iveda US by Iveda Taiwan added back to Accounts and Other Payables
0001641172-25-004833 20231231 Accounts Receivable Net Current 281049.0000 USD 0 us-gaap/2024
0001641172-25-004833 20231231 Accumulated Other Comprehensive Income Loss Net Of Tax -962.0000 USD 0 us-gaap/2024 Restatement= Revision Of Prior Period Reclassification Adjustment;
0001641172-25-004833 20241231 Assets Current 5026415.0000 USD 0 us-gaap/2024
0001641172-25-004833 20231231 Cash And Cash Equivalents At Carrying Value 4754597.0000 USD 0 us-gaap/2024 Restatement= Scenario Previously Reported;
0001641172-25-004833 20231231 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations -16092.0000 USD 0 us-gaap/2024 Restatement= Revision Of Prior Period Reclassification Adjustment;
0001641172-25-004833 20231231 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations 4754596.0000 USD 0 us-gaap/2024 Restatement= Scenario Previously Reported;
0001641172-25-004833 20231231 Common Stock Par Or Stated Value Per Share 0.0000 USD 0 us-gaap/2024
0001641172-25-004833 20241231 Common Stock Shares Outstanding 2808071.0000 shares 0 us-gaap/2024
0001641172-25-004833 20231231 Cost Of Revenue 4495393.0000 USD 4 us-gaap/2024 Geographical= T W;
0001641172-25-004833 20231231 Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations 1252.0000 USD 4 us-gaap/2024 Restatement= Scenario Previously Reported;
0001641172-25-004833 20231231 Gain Loss On Investments 180000.0000 USD 4 us-gaap/2024 Restatement= Restated;
0001641172-25-004833 20231231 Gain Loss On Investments USD 4 us-gaap/2024 Restatement= Scenario Previously Reported;
0001641172-25-004833 20241231 Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest -4007247.0000 USD 4 us-gaap/2024 Geographical= U S;
0001641172-25-004833 20231231 Income Loss From Equity Method Investments -180000.0000 USD 4 us-gaap/2024
0001641172-25-004833 20241231 Income Tax Expense Benefit 32385.0000 USD 4 us-gaap/2024
0001641172-25-004833 20241231 Investment Income Interest 113728.0000 USD 4 us-gaap/2024
0001641172-25-004833 20241231 Liabilities And Stockholders Equity 5179516.0000 USD 0 us-gaap/2024
0001641172-25-004833 20231231 Liabilities Current 1657685.0000 USD 0 us-gaap/2024
0001641172-25-004833 20231231 Net Cash Provided By Used In Financing Activities 1023833.0000 USD 4 us-gaap/2024
0001641172-25-004833 20241231 Net Cash Provided By Used In Operating Activities -4419748.0000 USD 4 us-gaap/2024
0001641172-25-004833 20231231 Net Income Loss -4142666.0000 USD 4 us-gaap/2024
0001641172-25-004833 20241231 Net Income Loss USD 4 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001641172-25-004833 20241231 Net Income Loss -3980820.0000 USD 4 us-gaap/2024 Equity Components= Retained Earnings;
0001641172-25-004833 20231231 Operating Income Loss 180000.0000 USD 4 us-gaap/2024 Restatement= Revision Of Prior Period Reclassification Adjustment;
0001641172-25-004833 20231231 Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax -775.0000 USD 4 us-gaap/2024
0001641172-25-004833 20231231 Other Comprehensive Income Loss Net Of Tax USD 4 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001641172-25-004833 20231231 Payments To Acquire Property Plant And Equipment 792612.0000 USD 4 us-gaap/2024 Restatement= Revision Of Prior Period Reclassification Adjustment;
0001641172-25-004833 20241231 Payments To Acquire Property Plant And Equipment 2608.0000 USD 4 us-gaap/2024
0001641172-25-004833 20241231 Preferred Stock Shares Outstanding 0.0000 shares 0 us-gaap/2024 Class Of Stock= Series B Preferred Stock;
0001641172-25-004833 20231231 Property Plant And Equipment Net 98575.0000 USD 0 us-gaap/2024
0001641172-25-004833 20231231 Property Plant And Equipment Net 1173.0000 USD 0 us-gaap/2024 Balance Sheet Location= Accounts Payable And Accrued Liabilities; Restatement= Revision Of Prior Period Reclassification Adjustment;
0001641172-25-004833 20231231 Research And Development Expense 792612.0000 USD 4 us-gaap/2024 Restatement= Revision Of Prior Period Reclassification Adjustment;
0001641172-25-004833 20231231 Revenue From Contract With Customer Excluding Assessed Tax 156701.0000 USD 4 us-gaap/2024 Contract With Customer Sales Channel= Municipalities;
0001641172-25-004833 20241231 Revenue From Contract With Customer Excluding Assessed Tax 6020639.0000 USD 4 us-gaap/2024
0001641172-25-004833 20241231 Revenue From Contract With Customer Excluding Assessed Tax 5592395.0000 USD 4 us-gaap/2024 Product Or Service= Equipment Sales;
0001641172-25-004833 20241231 Share Based Compensation 122600.0000 USD 4 us-gaap/2024
0001641172-25-004833 20221231 Shares Outstanding 2021236.0000 shares 0 us-gaap/2024 Equity Components= Common Stock; Restatement= Restatement Adjustment;
0001641172-25-004833 20231231 Shares Outstanding 2021236.0000 shares 0 us-gaap/2024 Equity Components= Common Stock; Restatement= Restated;
0001641172-25-004833 20241231 Short Term Borrowings 427025.0000 USD 0 us-gaap/2024
0001641172-25-004833 20221231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 5802571.0000 USD 0 us-gaap/2024 Restatement= Restatement Adjustment;
0001641172-25-004833 20231231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 4648480.0000 USD 0 us-gaap/2024
0001641172-25-004833 20231231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 54065775.0000 USD 0 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001641172-25-009950 20241231 Additional Paid In Capital 55962337.0000 USD 0 us-gaap/2024
0001641172-25-009950 20241231 Common Stock Shares Outstanding 2808071.0000 shares 0 us-gaap/2024
0001641172-25-009950 20250331 Common Stock Value 28.0000 USD 0 us-gaap/2024
0001641172-25-009950 20240331 Earnings Per Share Basic -0.6400 USD 1 us-gaap/2024
0001641172-25-009950 20240331 Earnings Per Share Basic -0.6400 USD 1 us-gaap/2024 Restatement= Restated;
0001641172-25-009950 20240331 Gross Profit 181880.0000 USD 1 us-gaap/2024
0001641172-25-009950 20240331 Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest -42376.0000 USD 1 us-gaap/2024 Geographical= T W;
0001641172-25-009950 20250331 Income Taxes Paid Net 476.0000 USD 1 us-gaap/2024
0001641172-25-009950 20240331 Increase Decrease In Inventories 177843.0000 USD 1 us-gaap/2024
0001641172-25-009950 20250331 Increase Decrease In Other Current Assets -138253.0000 USD 1 us-gaap/2024
0001641172-25-009950 20240331 Investment Income Interest 52595.0000 USD 1 us-gaap/2024
0001641172-25-009950 20250331 Investment Income Interest 15261.0000 USD 1 us-gaap/2024
0001641172-25-009950 20241231 Long Term Debt Current 122007.0000 USD 0 us-gaap/2024
0001641172-25-009950 20240331 Net Cash Provided By Used In Investing Activities USD 1 us-gaap/2024
0001641172-25-009950 20240331 Net Cash Provided By Used In Investing Activities USD 1 us-gaap/2024 Restatement= Restated;
0001641172-25-009950 20250331 Net Cash Provided By Used In Investing Activities 109.0000 USD 1 us-gaap/2024
0001641172-25-009950 20240331 Net Cash Provided By Used In Operating Activities -1112075.0000 USD 1 us-gaap/2024 Restatement= Scenario Previously Reported;
0001641172-25-009950 20240331 Net Income Loss USD 1 us-gaap/2024 Equity Components= Common Stock;
0001641172-25-009950 20240331 Net Income Loss -1289596.0000 USD 1 us-gaap/2024 Equity Components= Retained Earnings;
0001641172-25-009950 20250331 Net Income Loss USD 1 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001641172-25-009950 20240331 Operating Expenses 207705.0000 USD 1 us-gaap/2024 Geographical= T W;
0001641172-25-009950 20240331 Operating Income Loss -1331879.0000 USD 1 us-gaap/2024
0001641172-25-009950 20241231 Other Assets Current 435052.0000 USD 0 us-gaap/2024
0001641172-25-009950 20241231 Preferred Stock Shares Outstanding 0.0000 shares 0 us-gaap/2024
0001641172-25-009950 20240331 Proceeds From Repayments Of Short Term Debt -85955.0000 USD 1 us-gaap/2024
0001641172-25-009950 20241231 Property Plant And Equipment Net 68677.0000 USD 0 us-gaap/2024
0001641172-25-009950 20231231 Research And Development Expense 792612.0000 USD 4 us-gaap/2024 Restatement= Revision Of Prior Period Reclassification Adjustment;
0001641172-25-009950 20240331 Retained Earnings Accumulated Deficit -1435500.0000 USD 0 us-gaap/2024 Restatement= Revision Of Prior Period Reclassification Adjustment;
0001641172-25-009950 20241231 Retained Earnings Accumulated Deficit -53176717.0000 USD 0 us-gaap/2024
0001641172-25-009950 20240331 Revenue From Contract With Customer Excluding Assessed Tax 84707.0000 USD 1 us-gaap/2024 Geographical= U S;
0001641172-25-009950 20240331 Revenue From Contract With Customer Excluding Assessed Tax 119728.0000 USD 1 us-gaap/2024 Product Or Service= Service Revenue;
0001641172-25-009950 20240331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest -50485493.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings;
0001641172-25-009950 20250331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 1700887.0000 USD 0 us-gaap/2024
0001641172-25-009950 20240331 Weighted Average Number Of Diluted Shares Outstanding 2021237.0000 shares 1 us-gaap/2024 Restatement= Scenario Previously Reported;
0001641172-25-009950 20250331 Research And Development Expense 33000.0000 USD 1 us-gaap/2024
0001641172-25-015284 20231231 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 104600.0000 USD 4 us-gaap/2024
0001641172-25-015284 20231231 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 104600.0000 USD 4 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001641172-25-015284 20231231 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value USD 4 us-gaap/2024 Equity Components= Common Stock;
0001641172-25-015284 20231231 Adjustments To Additional Paid In Capital Warrant Issued USD 4 us-gaap/2024 Equity Components= Common Stock;
0001641172-25-015284 20231231 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations -16092.0000 USD 0 us-gaap/2024 Restatement= Revision Of Prior Period Reclassification Adjustment;
0001641172-25-015284 20231231 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect -15841.0000 USD 4 us-gaap/2024 Restatement= Revision Of Prior Period Reclassification Adjustment;
0001641172-25-015284 20241231 Common Stock Issued For Services 90000.0000 USD 4 0001641172-25-015284
0001641172-25-015284 20231231 Common Stock Shares Outstanding 2021236.0000 shares 0 us-gaap/2024
0001641172-25-015284 20231231 Deferred Income Tax Effects To Equity Prior Period Adjustment USD 4 0001641172-25-015284 Equity Components= Common Stock; Restatement= Scenario Previously Reported;
0001641172-25-015284 20231231 Deferred Income Tax Effects To Equity Prior Period Adjustment 346560.0000 USD 4 0001641172-25-015284 Equity Components= Retained Earnings; Restatement= Scenario Previously Reported;
0001641172-25-015284 20231231 Earnings Per Share Basic 2.0700 USD 4 us-gaap/2024 Restatement= Restated; Restated per share amount reflects a reverse stock split of the outstanding shares of our Common Stock at a ratio of 1-for-8 effected on September 17, 2024.
0001641172-25-015284 20231231 Earnings Per Share Diluted -2.0700 USD 4 us-gaap/2024
0001641172-25-015284 20231231 Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations 1252.0000 USD 4 us-gaap/2024 Restatement= Scenario Previously Reported;
0001641172-25-015284 20241231 Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest -4007247.0000 USD 4 us-gaap/2024 Geographical= U S;
0001641172-25-015284 20231231 Increase Decrease In Other Accounts Payable -522460.0000 USD 4 us-gaap/2024 Restatement= Scenario Previously Reported;
0001641172-25-015284 20231231 Interest Paid Net 9793.0000 USD 4 us-gaap/2024
0001641172-25-015284 20241231 Investment Income Interest 113728.0000 USD 4 us-gaap/2024
0001641172-25-015284 20241231 Liabilities And Stockholders Equity 5179516.0000 USD 0 us-gaap/2024
0001641172-25-015284 20231231 Long Term Debt Current USD 0 us-gaap/2024
0001641172-25-015284 20231231 Net Cash Provided By Used In Financing Activities 1023833.0000 USD 4 us-gaap/2024
0001641172-25-015284 20231231 Net Cash Provided By Used In Financing Activities 129778.0000 USD 4 us-gaap/2024 Income Statement Location= Additional Restricted Cash; Restatement= Revision Of Prior Period Reclassification Adjustment; Added Restricted Cash to Cash and Cash Equivalents
0001641172-25-015284 20231231 Net Cash Provided By Used In Investing Activities -792612.0000 USD 4 us-gaap/2024 Restatement= Revision Of Prior Period Reclassification Adjustment;
0001641172-25-015284 20241231 Net Cash Provided By Used In Investing Activities -2608.0000 USD 4 us-gaap/2024
0001641172-25-015284 20231231 Net Cash Provided By Used In Operating Activities -3333360.0000 USD 4 us-gaap/2024 Income Statement Location= Increase Decrease In Accounts And Other Payable; Restatement= Restated;
0001641172-25-015284 20231231 Net Cash Provided By Used In Operating Activities -2604645.0000 USD 4 us-gaap/2024 Restatement= Scenario Previously Reported;
0001641172-25-015284 20231231 Net Income Loss -4142666.0000 USD 4 us-gaap/2024
0001641172-25-015284 20241231 Operating Expenses 4356828.0000 USD 4 us-gaap/2024 Geographical= U S;
0001641172-25-015284 20231231 Operating Income Loss 180000.0000 USD 4 us-gaap/2024 Restatement= Restated;
0001641172-25-015284 20231231 Operating Income Loss 180000.0000 USD 4 us-gaap/2024 Restatement= Revision Of Prior Period Reclassification Adjustment;
0001641172-25-015284 20231231 Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax -775.0000 USD 4 us-gaap/2024
0001641172-25-015284 20231231 Other Comprehensive Income Loss Net Of Tax USD 4 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001641172-25-015284 20241231 Preferred Stock Shares Issued 0.0000 shares 0 us-gaap/2024 Class Of Stock= Series B Preferred Stock;
0001641172-25-015284 20231231 Property Plant And Equipment Net 1173.0000 USD 0 us-gaap/2024 Balance Sheet Location= Accounts Payable And Accrued Liabilities; Restatement= Revision Of Prior Period Reclassification Adjustment;
0001641172-25-015284 20231231 Research And Development Expense 797112.0000 USD 4 us-gaap/2024
0001641172-25-015284 20231231 Revenue From Contract With Customer Excluding Assessed Tax 6104478.0000 USD 4 us-gaap/2024 Contract With Customer Sales Channel= Commercial Enterprises;
0001641172-25-015284 20231231 Revenue From Contract With Customer Excluding Assessed Tax 148311.0000 USD 4 us-gaap/2024 Contract With Customer Sales Channel= Other;
0001641172-25-015284 20241231 Revenue From Contract With Customer Excluding Assessed Tax 762660.0000 USD 4 us-gaap/2024 Contract With Customer Sales Channel= Distributors;
0001641172-25-015284 20241231 Short Term Borrowings 427025.0000 USD 0 us-gaap/2024
0001641172-25-015284 20241231 Short Term Borrowings 91505.0000 USD 0 us-gaap/2024 Related Party Transactions By Related Party= Hua Nam Bank;
0001641172-25-015284 20221231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 7223190.0000 USD 0 us-gaap/2024
0001641172-25-015284 20221231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 52497045.0000 USD 0 us-gaap/2024 Equity Components= Additional Paid In Capital; Restatement= Restated;
0001641172-25-015284 20221231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 19.0000 USD 0 us-gaap/2024 Equity Components= Common Stock;
0001641172-25-015284 20221231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 5802571.0000 USD 0 us-gaap/2024 Restatement= Restatement Adjustment;
0001641172-25-015284 20231231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 54065775.0000 USD 0 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001641172-25-015284 20231231 Stock Issued During Period Value Issued For Services USD 4 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001641172-25-015284 20241231 Stock Issued During Period Value Issued For Services 90000.0000 USD 4 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001641172-25-015284 20241231 Stock Issued During Period Value Issued For Services USD 4 us-gaap/2024 Equity Components= Retained Earnings;
0001641172-25-015284 20241231 Stock Issued During Period Value New Issues 1683970.0000 USD 4 us-gaap/2024
0001641172-25-015284 20241231 Stock Issued During Period Value New Issues USD 4 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001641172-25-015284 20241231 Stock Issued During Reverse Split Fractional Shares Value -2.0000 USD 4 0001641172-25-015284 Equity Components= Additional Paid In Capital;
0001641172-25-009950 20241231 Accounts Receivable Net Current 1277635.0000 USD 0 us-gaap/2024
0001641172-25-009950 20250331 Additional Paid In Capital 55962337.0000 USD 0 us-gaap/2024
0001641172-25-009950 20240331 Adjustments To Additional Paid In Capital Other -3690.0000 USD 1 us-gaap/2024
0001641172-25-009950 20240331 Adjustments To Additional Paid In Capital Other -3690.0000 USD 1 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001641172-25-009950 20240331 Cash And Cash Equivalents At Carrying Value 3899152.0000 USD 0 us-gaap/2024 Restatement= Scenario Previously Reported;
0001641172-25-009950 20241231 Cash And Cash Equivalents At Carrying Value 2629287.0000 USD 0 us-gaap/2024
0001641172-25-009950 20250331 Cash And Cash Equivalents At Carrying Value 1602567.0000 TWD 0 us-gaap/2024
0001641172-25-009950 20241231 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations 2658300.0000 USD 0 us-gaap/2024
0001641172-25-009950 20250331 Common Stock Shares Issued 2808071.0000 shares 0 us-gaap/2024
0001641172-25-009950 20241231 Common Stock Value 28.0000 USD 0 us-gaap/2024
0001641172-25-009950 20250331 Cost Of Revenue 1186365.0000 USD 1 us-gaap/2024
0001641172-25-009950 20250331 Depreciation Depletion And Amortization 7285.0000 USD 1 us-gaap/2024
0001641172-25-009950 20250331 Earnings Per Share Basic -0.2800 USD 1 us-gaap/2024
0001641172-25-009950 20240331 Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest -1215875.0000 USD 1 us-gaap/2024 Geographical= U S;
0001641172-25-009950 20250331 Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest -793672.0000 USD 1 us-gaap/2024
0001641172-25-009950 20250331 Income Tax Expense Benefit USD 1 us-gaap/2024 Geographical= T W;
0001641172-25-009950 20250331 Increase Decrease In Inventories 69508.0000 USD 1 us-gaap/2024
0001641172-25-009950 20240331 Increase Decrease In Operating Lease Liability USD 1 us-gaap/2024
0001641172-25-009950 20240331 Increase Decrease In Other Noncurrent Assets -177855.0000 USD 1 us-gaap/2024
0001641172-25-009950 20250331 Increase Decrease In Right Of Use Asset -3314.0000 USD 1 0001641172-25-009950
0001641172-25-009950 20250331 Liabilities And Stockholders Equity 4528325.0000 USD 0 us-gaap/2024
0001641172-25-009950 20250331 Net Cash Provided By Used In Operating Activities -125966.0000 USD 1 us-gaap/2024
0001641172-25-009950 20240331 Net Income Loss -1289596.0000 USD 1 us-gaap/2024
0001641172-25-009950 20240331 Net Income Loss USD 1 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001641172-25-009950 20250331 Net Income Loss -793672.0000 USD 1 us-gaap/2024 Equity Components= Retained Earnings;
0001641172-25-009950 20250331 Nonoperating Income Expense 41887.0000 USD 1 us-gaap/2024
0001641172-25-009950 20240331 Operating Expenses 1342863.0000 USD 1 us-gaap/2024 Restatement= Scenario Previously Reported;
0001641172-25-009950 20250331 Operating Income Loss -835559.0000 USD 1 us-gaap/2024
0001641172-25-009950 20250331 Operating Lease Liability Noncurrent 148027.0000 USD 0 us-gaap/2024
0001641172-25-009950 20250331 Other Comprehensive Income Loss Net Of Tax -10880.0000 USD 1 us-gaap/2024
0001641172-25-009950 20250331 Other Comprehensive Income Loss Net Of Tax -10880.0000 USD 1 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001641172-25-009950 20250331 Preferred Stock Par Or Stated Value Per Share 0.0000 USD 0 us-gaap/2024
0001641172-25-009950 20250331 Preferred Stock Shares Authorized 1250000.0000 shares 0 us-gaap/2024 Class Of Stock= Series A Preferred Stock;
0001641172-25-009950 20250331 Preferred Stock Shares Authorized 500.0000 shares 0 us-gaap/2024 Class Of Stock= Series B Preferred Stock;
0001641172-25-009950 20250331 Preferred Stock Shares Authorized 12500000.0000 shares 0 us-gaap/2024 Range= Maximum;
0001641172-25-009950 20250331 Preferred Stock Shares Outstanding 0.0000 shares 0 us-gaap/2024
0001641172-25-009950 20240331 Research And Development Expense 188400.0000 USD 1 us-gaap/2024
0001641172-25-009950 20240331 Retained Earnings Accumulated Deficit -50485493.0000 USD 0 us-gaap/2024 Restatement= Restated;
0001641172-25-009950 20240331 Revenue From Contract With Customer Excluding Assessed Tax 346766.0000 USD 1 us-gaap/2024
0001641172-25-009950 20250331 Revenue From Contract With Customer Excluding Assessed Tax 1474576.0000 USD 1 us-gaap/2024
0001641172-25-009950 20231231 Shares Outstanding 2021236.0000 shares 0 us-gaap/2024 Equity Components= Common Stock;
0001641172-25-009950 20250331 Short Term Borrowings 90220.0000 USD 0 us-gaap/2024 Related Party Transactions By Related Party= Hua Nam Bank;
0001641172-25-009950 20240331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 3320603.0000 USD 0 us-gaap/2024
0001641172-25-009950 20241231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 2505439.0000 USD 0 us-gaap/2024
0001641172-25-009950 20241231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest -53176717.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings;
0001641172-25-009950 20250331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest -53970389.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings;
0001641172-25-009950 20250331 Net Income Loss -847874.0000 USD 1 us-gaap/2024 Geographical= U S;
0001641172-25-009950 20241231 Accounts Payable And Other Accrued Liabilities Current 1748857.0000 USD 0 us-gaap/2024
0001641172-25-009950 20240331 Accumulated Other Comprehensive Income Loss Net Of Tax -258347.0000 USD 0 us-gaap/2024 Restatement= Restated;
0001641172-25-009950 20240331 Adjustments To Additional Paid In Capital Other USD 1 us-gaap/2024 Equity Components= Retained Earnings;
0001641172-25-009950 20231231 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations 4868282.0000 USD 0 us-gaap/2024
0001641172-25-009950 20250331 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations 2519088.0000 USD 0 us-gaap/2024
0001641172-25-009950 20241231 Common Stock Shares Authorized 300000000.0000 shares 0 us-gaap/2024
0001641172-25-009950 20240331 Earnings Per Share Diluted -0.6400 USD 1 us-gaap/2024
0001641172-25-009950 20240331 Earnings Per Share Diluted -0.6400 USD 1 us-gaap/2024 Restatement= Restated;
0001641172-25-009950 20250331 Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations -14194.0000 USD 1 us-gaap/2024
0001641172-25-009950 20250331 Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest 54202.0000 USD 1 us-gaap/2024 Geographical= T W;
0001641172-25-009950 20250331 Interest Expense Nonoperating 5796.0000 USD 1 us-gaap/2024
0001641172-25-009950 20250331 Liabilities Current 2338580.0000 USD 0 us-gaap/2024
0001641172-25-009950 20240331 Net Cash Provided By Used In Financing Activities 525609.0000 USD 1 us-gaap/2024
0001641172-25-009950 20250331 Net Cash Provided By Used In Financing Activities 839.0000 USD 1 us-gaap/2024
0001641172-25-009950 20240331 Net Cash Provided By Used In Operating Activities -181398.0000 USD 1 us-gaap/2024 Restatement= Revision Of Prior Period Reclassification Adjustment;
0001641172-25-009950 20250331 Operating Expenses 941813.0000 USD 1 us-gaap/2024 Geographical= U S;
0001641172-25-009950 20250331 Other Assets Noncurrent 71721.0000 USD 0 us-gaap/2024
0001641172-25-009950 20241231 Preferred Stock Par Or Stated Value Per Share 0.0000 USD 0 us-gaap/2024
0001641172-25-009950 20250331 Preferred Stock Shares Authorized 12500000.0000 shares 0 us-gaap/2024
0001641172-25-009950 20250331 Preferred Stock Shares Issued 0.0000 shares 0 us-gaap/2024
0001641172-25-009950 20240331 Proceeds From Issuance Of Common Stock -3690.0000 USD 1 us-gaap/2024
0001641172-25-009950 20250331 Proceeds From Repayments Of Notes Payable -37070.0000 USD 1 us-gaap/2024
0001641172-25-009950 20250331 Proceeds From Sale Of Property Plant And Equipment 109.0000 USD 1 us-gaap/2024
0001641172-25-009950 20240331 Property Plant And Equipment Net 90237.0000 USD 0 us-gaap/2024 Restatement= Restated;
0001641172-25-009950 20240331 Retained Earnings Accumulated Deficit -49049993.0000 USD 0 us-gaap/2024 Restatement= Scenario Previously Reported;
0001641172-25-009950 20250331 Revenue From Contract With Customer Excluding Assessed Tax 18131.0000 USD 1 us-gaap/2024 Contract With Customer Sales Channel= Municipalities;
0001641172-25-009950 20250331 Revenue From Contract With Customer Excluding Assessed Tax 65844.0000 USD 1 us-gaap/2024 Product Or Service= Service Revenue;
0001641172-25-009950 20240331 Selling General And Administrative Expense 1325359.0000 USD 1 us-gaap/2024
0001641172-25-009950 20250331 Selling General And Administrative Expense 1090770.0000 USD 1 us-gaap/2024
0001641172-25-009950 20241231 Shares Outstanding 2808071.0000 shares 0 us-gaap/2024 Equity Components= Common Stock;
0001641172-25-009950 20231231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest -221418.0000 USD 0 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001641172-25-009950 20241231 Accumulated Other Comprehensive Income Loss Net Of Tax -280209.0000 USD 0 us-gaap/2024
0001641172-25-009950 20240331 Cash And Cash Equivalents At Carrying Value 3890069.0000 USD 0 us-gaap/2024 Restatement= Restated;
0001641172-25-009950 20240331 Cash And Cash Equivalents At Carrying Value -9083.0000 USD 0 us-gaap/2024 Restatement= Revision Of Prior Period Reclassification Adjustment;
0001641172-25-009950 20241231 Cash And Cash Equivalents At Carrying Value 1025675.0000 TWD 0 us-gaap/2024
0001641172-25-009950 20250331 Cash And Cash Equivalents At Carrying Value 2490482.0000 USD 0 us-gaap/2024
0001641172-25-009950 20250331 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect -139212.0000 USD 1 us-gaap/2024
0001641172-25-009950 20231231 Common Stock Shares Authorized 300000000.0000 shares 0 us-gaap/2024
0001641172-25-009950 20250331 Common Stock Shares Authorized 300000000.0000 shares 0 us-gaap/2024
0001641172-25-009950 20240331 Cost Of Revenue 61405.0000 USD 1 us-gaap/2024 Geographical= U S;
0001641172-25-009950 20250331 Cost Of Revenue 1002737.0000 USD 1 us-gaap/2024 Geographical= T W;
0001641172-25-009950 20250331 Deferred Costs Current 359388.0000 USD 0 us-gaap/2024
0001641172-25-009950 20240331 Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest -1087356.0000 USD 1 us-gaap/2024 Restatement= Scenario Previously Reported;
0001641172-25-009950 20240331 Income Taxes Paid Net 682.0000 USD 1 us-gaap/2024
0001641172-25-009950 20240331 Increase Decrease In Other Current Assets 130269.0000 USD 1 us-gaap/2024
0001641172-25-009950 20250331 Increase Decrease In Other Noncurrent Assets -12704.0000 USD 1 us-gaap/2024
0001641172-25-009950 20250331 Inventory Net 217628.0000 USD 0 us-gaap/2024
0001641172-25-009950 20250331 Liabilities 2827438.0000 USD 0 us-gaap/2024
0001641172-25-009950 20240331 Net Cash Provided By Used In Investing Activities -188400.0000 USD 1 us-gaap/2024 Restatement= Scenario Previously Reported;
0001641172-25-009950 20250331 Operating Lease Right Of Use Asset 179354.0000 USD 0 us-gaap/2024
0001641172-25-009950 20250331 Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax -10880.0000 USD 1 us-gaap/2024
0001641172-25-009950 20240331 Other Comprehensive Income Loss Net Of Tax USD 1 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001641172-25-009950 20250331 Other Comprehensive Income Loss Net Of Tax USD 1 us-gaap/2024 Equity Components= Retained Earnings;
0001641172-25-009950 20241231 Preferred Stock Shares Authorized 12500000.0000 shares 0 us-gaap/2024
0001641172-25-009950 20241231 Preferred Stock Shares Issued 0.0000 shares 0 us-gaap/2024
0001641172-25-009950 20250331 Present Value Of Right Of Use Asset And Lease Obligations On New Lease 182668.0000 USD 1 0001641172-25-009950
0001641172-25-009950 20240331 Proceeds From Sale Of Property Plant And Equipment USD 1 us-gaap/2024
0001641172-25-009950 20240331 Research And Development Expense 188400.0000 USD 1 us-gaap/2024 Restatement= Revision Of Prior Period Reclassification Adjustment;
0001641172-25-009950 20240331 Revenue From Contract With Customer Excluding Assessed Tax 32630.0000 USD 1 us-gaap/2024 Contract With Customer Sales Channel= Municipalities;
0001641172-25-009950 20240331 Revenue From Contract With Customer Excluding Assessed Tax USD 1 us-gaap/2024 Contract With Customer Sales Channel= Other;
0001641172-25-009950 20240331 Revenue From Contract With Customer Excluding Assessed Tax 262059.0000 USD 1 us-gaap/2024 Geographical= T W;
0001641172-25-009950 20240331 Revenue From Contract With Customer Excluding Assessed Tax 227038.0000 USD 1 us-gaap/2024 Product Or Service= Equipment Sales;
0001641172-25-009950 20250331 Revenue From Contract With Customer Excluding Assessed Tax 1408732.0000 USD 1 us-gaap/2024 Product Or Service= Equipment Sales;
0001641172-25-009950 20250331 Shares Outstanding 2808071.0000 shares 0 us-gaap/2024 Equity Components= Common Stock;
0001641172-25-009950 20241231 Short Term Borrowings 152509.0000 USD 0 us-gaap/2024 Related Party Transactions By Related Party= Chang Hwa Bank;
0001641172-25-009950 20241231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest -280209.0000 USD 0 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001641172-25-009950 20241231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 55962337.0000 USD 0 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001641172-25-009950 20241231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 28.0000 USD 0 us-gaap/2024 Equity Components= Common Stock;
0001641172-25-009950 20240331 Weighted Average Number Of Shares Outstanding Basic 2021237.0000 shares 1 us-gaap/2024 Restatement= Scenario Previously Reported;
0001641172-25-015284 20231231 Accounts Payable And Other Accrued Liabilities Current 200000.0000 USD 0 us-gaap/2024 Restatement= Revision Of Prior Period Reclassification Adjustment; The intercompany amount due to Iveda Taiwan was understated by $200,000 related to a payment made on behalf of Iveda US by Iveda Taiwan added back to Accounts and Other Payables
0001641172-25-015284 20231231 Accounts Receivable Net Current 281049.0000 USD 0 us-gaap/2024
0001641172-25-015284 20231231 Accumulated Other Comprehensive Income Loss Net Of Tax -962.0000 USD 0 us-gaap/2024 Restatement= Revision Of Prior Period Reclassification Adjustment;
0001641172-25-015284 20231231 Accounts Payable And Other Accrued Liabilities Current USD 0 us-gaap/2024 Restatement= Restated;
0001641172-25-015284 20241231 Additional Paid In Capital 55962337.0000 USD 0 us-gaap/2024
0001641172-25-015284 20231231 Adjustments To Additional Paid In Capital Warrant Issued 2700.0000 USD 4 us-gaap/2024
0001641172-25-015284 20231231 Assets Current 5909427.0000 USD 0 us-gaap/2024
0001641172-25-015284 20241231 Common Stock Shares Issued 2808071.0000 shares 0 us-gaap/2024
0001641172-25-015284 20241231 Common Stock Shares Outstanding 2808071.0000 shares 0 us-gaap/2024
0001641172-25-015284 20241231 Comprehensive Income Net Of Tax -4039612.0000 USD 4 us-gaap/2024
0001641172-25-015284 20231231 Depreciation Depletion And Amortization 19753.0000 USD 4 us-gaap/2024
0001641172-25-015284 20231231 Earnings Per Share Diluted 2.0700 USD 4 us-gaap/2024 Restatement= Restated;
0001641172-25-015284 20231231 Gain Loss On Investments USD 4 us-gaap/2024 Restatement= Scenario Previously Reported;
0001641172-25-015284 20231231 Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest -4124358.0000 USD 4 us-gaap/2024
0001641172-25-015284 20231231 Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest -4268395.0000 USD 4 us-gaap/2024 Geographical= U S;
0001641172-25-015284 20241231 Increase Decrease In Deferred Charges 507308.0000 USD 4 us-gaap/2024
0001641172-25-015284 20241231 Increase Decrease In Inventories -176395.0000 USD 4 us-gaap/2024
0001641172-25-015284 20231231 Increase Decrease In Other Accounts Payable -523633.0000 USD 4 us-gaap/2024
0001641172-25-015284 20231231 Increase Decrease In Other Accounts Payable -523633.0000 USD 4 us-gaap/2024 Restatement= Restated;
0001641172-25-015284 20241231 Increase Decrease In Other Current Assets -528.0000 USD 4 us-gaap/2024
0001641172-25-015284 20240131 Long Term Debt 600000.0000 USD 0 us-gaap/2024 Longterm Debt Type= Term Loan;
0001641172-25-015284 20241231 Long Term Debt Current 122007.0000 USD 0 us-gaap/2024
0001641172-25-015284 20231231 Net Cash Provided By Used In Financing Activities 4868282.0000 USD 4 us-gaap/2024 Income Statement Location= Restated; Restatement= Revision Of Prior Period Reclassification Adjustment;
0001641172-25-015284 20231231 Net Cash Provided By Used In Investing Activities -265593.0000 USD 4 us-gaap/2024
0001641172-25-015284 20231231 Net Cash Provided By Used In Investing Activities -878205.0000 USD 4 us-gaap/2024 Restatement= Scenario Previously Reported;
0001641172-25-015284 20231231 Net Cash Provided By Used In Operating Activities -114930.0000 USD 4 us-gaap/2024 Income Statement Location= Additional Loss From Joint Venture; Restatement= Revision Of Prior Period Reclassification Adjustment;
0001641172-25-015284 20231231 Net Cash Provided By Used In Operating Activities -1173.0000 USD 4 us-gaap/2024 Income Statement Location= Increase Decrease In Accounts And Other Payable; Restatement= Revision Of Prior Period Reclassification Adjustment;
0001641172-25-015284 20231231 Net Income Loss USD 4 us-gaap/2024 Equity Components= Common Stock;
0001641172-25-015284 20231231 Net Income Loss -3235124.0000 USD 4 us-gaap/2024 Restatement= Scenario Previously Reported;
0001641172-25-015284 20241231 Net Income Loss USD 4 us-gaap/2024 Equity Components= Common Stock;
0001641172-25-015284 20231231 Nonoperating Income Expense -83483.0000 USD 4 us-gaap/2024
0001641172-25-015284 20231231 Operating Income Loss 143068.0000 USD 4 us-gaap/2024 Geographical= T W;
0001641172-25-015284 20241231 Other Assets Current 435052.0000 USD 0 us-gaap/2024
0001641172-25-015284 20231231 Payments To Acquire Other Property Plant And Equipment 85593.0000 USD 4 us-gaap/2024 Restatement= Restated;
0001641172-25-015284 20231231 Payments To Acquire Other Property Plant And Equipment 878205.0000 USD 4 us-gaap/2024 Restatement= Scenario Previously Reported;
0001641172-25-015284 20241231 Payments To Acquire Other Property Plant And Equipment 2608.0000 USD 4 us-gaap/2024
0001641172-25-015284 20231231 Preferred Stock Par Or Stated Value Per Share 0.0000 USD 0 us-gaap/2024
0001641172-25-015284 20241231 Preferred Stock Par Or Stated Value Per Share 0.0000 USD 0 us-gaap/2024
0001641172-25-015284 20231231 Preferred Stock Shares Outstanding 0.0000 shares 0 us-gaap/2024 Class Of Stock= Series B Preferred Stock;
0001641172-25-015284 20241231 Preferred Stock Shares Outstanding 0.0000 shares 0 us-gaap/2024 Class Of Stock= Series B Preferred Stock;
0001641172-25-015284 20241231 Proceeds From Repayments Of Notes Payable 498195.0000 USD 4 us-gaap/2024

Description
Field Name Field Description
adsh Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission.
tag The unique identifier (name) for a tag in a specific taxonomy release.
version For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined.
ddate The end date for the data value, rounded to the nearest month end.
qtrs The count of the number of quarters represented by the data value, rounded to the nearest whole number. “0” indicates it is a point-in-time value.
uom The unit of measure for the value.
segments Tags used to represent axis and member reporting.
coreg If specified, indicates a specific co-registrant, the parent company, or other entity (e.g., guarantor). NULL indicates the consolidated entity.
value The value. This is not scaled, it is as found in the Interactive Data file, but is limited to four digits to the right of the decimal point.
footnote The text of any superscripted footnotes on the value, as shown on the statement page, truncated to 512 characters, or if there is no footnote, then this field will be blank.

Tags

tag version custom abstract datatype iord crdr tlabel doc
Increase Decrease In Accounts Receivable us-gaap/2024 0 0 monetary D C Increase (Decrease) in Accounts Receivable The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.
Assets Current us-gaap/2024 0 0 monetary I D Assets, Current Amount of asset recognized for present right to economic benefit, classified as current.
Increase Decrease In Other Noncurrent Assets us-gaap/2024 0 0 monetary D C Increase (Decrease) in Other Noncurrent Assets Amount of increase (decrease) in noncurrent assets classified as other.
Operating Lease Liability Current us-gaap/2024 0 0 monetary I C Operating Lease, Liability, Current Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.
Revenue From Contract With Customer Excluding Assessed Tax us-gaap/2024 0 0 monetary D C Revenue from Contract with Customer, Excluding Assessed Tax Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.
Present Value Of Right Of Use Asset And Lease Obligations On New Lease 0001641172-25-009950 1 0 monetary D C Present Value of right of Use Asset and Lease Obligations on New Lease Present value of right of use asset and lease obligations on new lease.
Adjustments To Additional Paid In Capital Warrant Issued us-gaap/2024 0 0 monetary D C Adjustments to Additional Paid in Capital, Warrant Issued Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants.
Comprehensive Income Net Of Tax us-gaap/2024 0 0 monetary D C Comprehensive Income (Loss), Net of Tax, Attributable to Parent Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.
Payments To Acquire Equity Securities Fv Ni us-gaap/2024 0 0 monetary D C Payments to Acquire Equity Securities, FV-NI Amount of cash outflow to acquire investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as investing activity.
Payments To Acquire Property Plant And Equipment us-gaap/2024 0 0 monetary D C Payments to Acquire Property, Plant, and Equipment The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
Stockholders Equity Including Portion Attributable To Noncontrolling Interest us-gaap/2024 0 0 monetary I C Equity, Including Portion Attributable to Noncontrolling Interest Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity.
Gain Loss On Investments us-gaap/2024 0 0 monetary D C Gain (Loss) on Investments Amount of realized and unrealized gain (loss) on investment.
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest us-gaap/2024 0 0 monetary D C Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.
Liabilities us-gaap/2024 0 0 monetary I C Liabilities Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others.
Liabilities And Stockholders Equity us-gaap/2024 0 0 monetary I C Liabilities and Equity Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
Retained Earnings Accumulated Deficit us-gaap/2024 0 0 monetary I C Retained Earnings (Accumulated Deficit) Amount of accumulated undistributed earnings (deficit).
Stock Issued During Period Shares Issued For Services us-gaap/2024 0 0 shares D Stock Issued During Period, Shares, Issued for Services Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.
Deferred Income Tax Effects To Equity Prior Period Adjustment 0001641172-25-004833 1 0 monetary D D DeferredIncomeTaxEffectsToEquityPriorPeriodAdjustment Deferred income tax effects to equity prior period adjustment.
Increase Decrease In Right Of Use Asset 0001641172-25-009950 1 0 monetary D C IncreaseDecreaseInRightOfUseAsset Changes in right of use asset.
Stock Issued During Reverse Split Fractional Shares Value 0001641172-25-015284 1 0 monetary D C Reverse Split fractional shares Stock issued during reverse split fractional shares value.
Deferred Income Tax Effects To Equity Prior Period Adjustment 0001641172-25-015284 1 0 monetary D D DeferredIncomeTaxEffectsToEquityPriorPeriodAdjustment Deferred income tax effects to equity prior period adjustment.
Accounts Receivable Net Current us-gaap/2024 0 0 monetary I D Accounts Receivable, after Allowance for Credit Loss, Current Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.
Additional Paid In Capital us-gaap/2024 0 0 monetary I C Additional Paid in Capital Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.
Common Stock Par Or Stated Value Per Share us-gaap/2024 0 0 perShare I Common Stock, Par or Stated Value Per Share Face amount or stated value per share of common stock.
Common Stock Shares Outstanding us-gaap/2024 0 0 shares I Common Stock, Shares, Outstanding Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations us-gaap/2024 0 0 monetary D D Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.
Income Tax Expense Benefit us-gaap/2024 0 0 monetary D D Income Tax Expense (Benefit) Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Net Income Loss us-gaap/2024 0 0 monetary D C Net Income (Loss) Attributable to Parent The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Weighted Average Number Of Diluted Shares Outstanding us-gaap/2024 0 0 shares D Weighted Average Number of Shares Outstanding, Diluted The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Stock Issued During Reverse Split Fractional Shares 0001641172-25-015284 1 0 shares D Reverse Split fractional shares, shares Stock issued during reverse split fractional shares.
Accumulated Other Comprehensive Income Loss Net Of Tax us-gaap/2024 0 0 monetary I C Accumulated Other Comprehensive Income (Loss), Net of Tax Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source.
Adjustments To Additional Paid In Capital Other us-gaap/2024 0 0 monetary D C Adjustments to Additional Paid in Capital, Other Amount of other increase (decrease) in additional paid in capital (APIC).
Assets us-gaap/2024 0 0 monetary I D Assets Amount of asset recognized for present right to economic benefit.
Common Stock Shares Issued us-gaap/2024 0 0 shares I Common Stock, Shares, Issued Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Earnings Per Share Diluted us-gaap/2024 0 0 perShare D Earnings Per Share, Diluted The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
Gross Profit us-gaap/2024 0 0 monetary D C Gross Profit Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.
Long Term Debt us-gaap/2024 0 0 monetary I C Long-Term Debt Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.
Operating Lease Right Of Use Asset us-gaap/2024 0 0 monetary I D Operating Lease, Right-of-Use Asset Amount of lessee's right to use underlying asset under operating lease.
Other Assets Noncurrent us-gaap/2024 0 0 monetary I D Other Assets, Noncurrent Amount of noncurrent assets classified as other.
Cash And Cash Equivalents At Carrying Value us-gaap/2024 0 0 monetary I D Cash and Cash Equivalents, at Carrying Value Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.
Cost Of Revenue us-gaap/2024 0 0 monetary D D Cost of Revenue The aggregate cost of goods produced and sold and services rendered during the reporting period.
Depreciation Depletion And Amortization us-gaap/2024 0 0 monetary D D Depreciation, Depletion and Amortization The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
Interest Expense Nonoperating us-gaap/2024 0 0 monetary D D Interest Expense, Nonoperating Amount of interest expense classified as nonoperating.
Liabilities Current us-gaap/2024 0 0 monetary I C Liabilities, Current Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax us-gaap/2024 0 0 monetary D C Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.
Preferred Stock Shares Issued us-gaap/2024 0 0 shares I Preferred Stock, Shares Issued Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt.
Selling General And Administrative Expense us-gaap/2024 0 0 monetary D D Selling, General and Administrative Expense The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.
Share Based Compensation us-gaap/2024 0 0 monetary D D Share-Based Payment Arrangement, Noncash Expense Amount of noncash expense for share-based payment arrangement.
Stock Issued During Period Value Issued For Services us-gaap/2024 0 0 monetary D C Stock Issued During Period, Value, Issued for Services Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.
Stock Issued During Period Value Stock Warrants Exercised 0001641172-25-015284 1 0 monetary D C Exercise of warrants issued August 2022 Stock issued during period value stock warrants exercised.
Income Taxes Paid Net us-gaap/2024 0 0 monetary D C Income Taxes Paid, Net Amount, after refund, of cash paid to foreign, federal, state, and local jurisdictions as income tax.
Increase Decrease In Inventories us-gaap/2024 0 0 monetary D C Increase (Decrease) in Inventories The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.
Nonoperating Income Expense us-gaap/2024 0 0 monetary D C Nonoperating Income (Expense) The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Other Comprehensive Income Loss Net Of Tax us-gaap/2024 0 0 monetary D C Other Comprehensive Income (Loss), Net of Tax Amount after tax and reclassification adjustments of other comprehensive income (loss).
Preferred Stock Value us-gaap/2024 0 0 monetary I C Preferred Stock, Value, Issued Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.
Proceeds From Repayments Of Notes Payable us-gaap/2024 0 0 monetary D D Proceeds from (Repayments of) Notes Payable Amount of cash inflow (outflow) from long-term debt supported by a written promise to pay an obligation.
Proceeds From Sale Of Property Plant And Equipment us-gaap/2024 0 0 monetary D D Proceeds from Sale of Property, Plant, and Equipment The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.
Stock Issued During Period Shares Stock Warrants Exercised 0001641172-25-004833 1 0 shares D Exercise of warrants issued August 2022, shares Stock Issued During Period Shares Stock Warrants Exercised.
Stock Issued During Reverse Split Fractional Shares 0001641172-25-004833 1 0 shares D Reverse Split fractional shares, shares Stock issued during reverse split fractional shares.
Stock Issued During Period Shares Stock Warrants Exercised 0001641172-25-015284 1 0 shares D Exercise of warrants issued August 2022, shares Stock Issued During Period Shares Stock Warrants Exercised.
Accounts Payable And Other Accrued Liabilities Current us-gaap/2024 0 0 monetary I C Accounts Payable and Other Accrued Liabilities, Current Amount of liabilities incurred to vendors for goods and services received, and accrued liabilities classified as other, payable within one year or the normal operating cycle, if longer.
Common Stock Warrants Issued For Services 0001641172-25-004833 1 0 monetary D D Common Stock Warrants Issued for Services Common stock warrants issued for services.
Increase Decrease In Deferred Charges us-gaap/2024 0 0 monetary D C Increase (Decrease) in Deferred Charges The increase (decrease) during the reporting period in the value of expenditures made during the current reporting period for benefits that will be received over a period of years. Deferred charges differ from prepaid expenses in that they usually extend over a long period of time and may or may not be regularly recurring costs of operation.
Net Cash Provided By Used In Operating Activities us-gaap/2024 0 0 monetary D Net Cash Provided by (Used in) Operating Activities Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
Operating Expenses us-gaap/2024 0 0 monetary D D Operating Expenses Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.
Operating Income Loss us-gaap/2024 0 0 monetary D C Operating Income (Loss) The net result for the period of deducting operating expenses from operating revenues.
Other Assets Current us-gaap/2024 0 0 monetary I D Other Assets, Current Amount of current assets classified as other.
Payments To Acquire Other Property Plant And Equipment us-gaap/2024 0 0 monetary D C Payments to Acquire Other Property, Plant, and Equipment Amount of cash outflow from the acquisition of or improvements to long-lived, physical assets used to produce goods and services and not intended for resale, classified as other.
Restricted Cash us-gaap/2024 0 0 monetary I D Restricted Cash Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.
Short Term Borrowings us-gaap/2024 0 0 monetary I C Short-Term Debt Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.
Stock Issued During Period Value Stock Warrants Exercised 0001641172-25-004833 1 0 monetary D C Exercise of warrants issued August 2022 Stock issued during period value stock warrants exercised.
Common Stock Value us-gaap/2024 0 0 monetary I C Common Stock, Value, Issued Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.
Income Loss From Equity Method Investments us-gaap/2024 0 0 monetary D C Income (Loss) from Equity Method Investments Amount of income (loss) for proportionate share of equity method investee's income (loss).
Increase Decrease In Other Current Assets us-gaap/2024 0 0 monetary D C Increase (Decrease) in Other Current Assets Amount of increase (decrease) in current assets classified as other.
Inventory Net us-gaap/2024 0 0 monetary I D Inventory, Net Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.
Proceeds From Repayments Of Short Term Debt us-gaap/2024 0 0 monetary D D Proceeds from (Repayments of) Short-Term Debt The net cash inflow or outflow for borrowing having initial term of repayment within one year or the normal operating cycle, if longer.
Research And Development Expense us-gaap/2024 0 0 monetary D D Research and Development Expense Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity.
Stock Issued During Period Shares New Issues us-gaap/2024 0 0 shares D Stock Issued During Period, Shares, New Issues Number of new stock issued during the period.
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect us-gaap/2024 0 0 monetary D D Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.
Stock Issued During Reverse Split Fractional Shares Value 0001641172-25-004833 1 0 monetary D C Reverse Split fractional shares Stock issued during reverse split fractional shares value.
Common Stock Warrants Issued For Services 0001641172-25-015284 1 0 monetary D D Common Stock Warrants Issued for Services Common stock warrants issued for services.
Common Stock Shares Authorized us-gaap/2024 0 0 shares I Common Stock, Shares Authorized The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Increase Decrease In Operating Lease Liability us-gaap/2024 0 0 monetary D D Increase (Decrease) in Operating Lease Liability Amount of increase (decrease) in obligation for operating lease.
Interest Paid Net us-gaap/2024 0 0 monetary D C Interest Paid, Excluding Capitalized Interest, Operating Activities Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.
Net Cash Provided By Used In Financing Activities us-gaap/2024 0 0 monetary D D Net Cash Provided by (Used in) Financing Activities Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Preferred Stock Par Or Stated Value Per Share us-gaap/2024 0 0 perShare I Preferred Stock, Par or Stated Value Per Share Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.
Shares Outstanding us-gaap/2024 0 0 shares I Shares, Outstanding Number of shares issued which are neither cancelled nor held in the treasury.
Common Stock Issued For Services 0001641172-25-015284 1 0 monetary D D Common Stock issued for Services Common stock issued for services.
Common Stock Issued For Services 0001641172-25-004833 1 0 monetary D D Common Stock issued for Services Common stock issued for services.
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value us-gaap/2024 0 0 monetary D C APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations us-gaap/2024 0 0 monetary I D Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.
Deferred Costs Current us-gaap/2024 0 0 monetary I D Deferred Costs, Current Sum of the carrying amounts as of the balance sheet date of deferred costs capitalized at the end of the reporting period that are expected to be charged against earnings within one year or the normal operating cycle, if longer.
Earnings Per Share Basic us-gaap/2024 0 0 perShare D Earnings Per Share, Basic The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Investment Income Interest us-gaap/2024 0 0 monetary D C Investment Income, Interest Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.
Net Cash Provided By Used In Investing Activities us-gaap/2024 0 0 monetary D D Net Cash Provided by (Used in) Investing Activities Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
Other Nonoperating Income Expense us-gaap/2024 0 0 monetary D C Other Nonoperating Income (Expense) Amount of income (expense) related to nonoperating activities, classified as other.
Preferred Stock Shares Authorized us-gaap/2024 0 0 shares I Preferred Stock, Shares Authorized The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.
Preferred Stock Shares Outstanding us-gaap/2024 0 0 shares I Preferred Stock, Shares Outstanding Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.
Proceeds From Issuance Of Common Stock us-gaap/2024 0 0 monetary D D Proceeds from Issuance of Common Stock The cash inflow from the additional capital contribution to the entity.
Stock Issued During Period Value New Issues us-gaap/2024 0 0 monetary D C Stock Issued During Period, Value, New Issues Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.
Increase Decrease In Other Accounts Payable us-gaap/2024 0 0 monetary D D Increase (Decrease) in Other Accounts Payable Amount of increase (decrease) in obligations classified as other, payable within one year or the normal operating cycle, if longer.
Long Term Debt Current us-gaap/2024 0 0 monetary I C Long-Term Debt, Current Maturities Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as current. Excludes lease obligation.
Long Term Debt Noncurrent us-gaap/2024 0 0 monetary I C Long-Term Debt, Excluding Current Maturities Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.
Operating Lease Liability Noncurrent us-gaap/2024 0 0 monetary I C Operating Lease, Liability, Noncurrent Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.
Property Plant And Equipment Net us-gaap/2024 0 0 monetary I D Property, Plant and Equipment, Net Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.
Weighted Average Number Of Shares Outstanding Basic us-gaap/2024 0 0 shares D Weighted Average Number of Shares Outstanding, Basic Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.

Description
Field Name Field Description
tag The unique identifier (name) for a tag in a specific taxonomy release.
version For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined.
custom 1 if tag is custom (version=adsh), 0 if it is standard. Note: This flag is technically redundant with the version and adsh columns.
abstract 1 if the tag is not used to represent a numeric fact.
datatype If abstract=1, then NULL, otherwise the data type (e.g., monetary) for the tag.
iord If abstract=1, then NULL; otherwise, “I” if the value is a point-in time, or “D” if the value is a duration.
crdr If datatype = monetary, then the tag’s natural accounting balance (debit or credit); if not defined, then NULL.
tlabel If a standard tag, then the label text provided by the taxonomy, otherwise the text provided by the filer. A tag which had neither would have a NULL value here.
doc The detailed definition for the tag. If a standard tag, then the text provided by the taxonomy, otherwise the text assigned by the filer. Some tags have neither, and this field is NULL.

Presentation of Statements

adsh report line stmt inpth rfile tag version plabel negating
0001641172-25-015284 2 8 BS 0 H Cash And Cash Equivalents At Carrying Value us-gaap/2024 Cash and Cash Equivalents 0
0001641172-25-009950 2 3 BS 0 H Cash And Cash Equivalents At Carrying Value us-gaap/2024 Cash and Cash Equivalents 0
0001641172-25-009950 2 4 BS 0 H Restricted Cash us-gaap/2024 Restricted Cash 0
0001641172-25-009950 2 5 BS 0 H Accounts Receivable Net Current us-gaap/2024 Accounts Receivable, Net 0
0001641172-25-009950 2 6 BS 0 H Deferred Costs Current us-gaap/2024 Deferred Cost of Goods 0
0001641172-25-009950 2 7 BS 0 H Inventory Net us-gaap/2024 Inventory, Net 0
0001641172-25-009950 2 8 BS 0 H Other Assets Current us-gaap/2024 Other Current Assets 0
0001641172-25-009950 2 9 BS 0 H Assets Current us-gaap/2024 Total Current Assets 0
0001641172-25-009950 2 10 BS 0 H Property Plant And Equipment Net us-gaap/2024 Property and Equipment, Net 0
0001641172-25-009950 2 11 BS 0 H Operating Lease Right Of Use Asset us-gaap/2024 Right of Use Asset, Net 0
0001641172-25-009950 2 12 BS 0 H Other Assets Noncurrent us-gaap/2024 Other Assets 0
0001641172-25-009950 2 13 BS 0 H Assets us-gaap/2024 Total Assets 0
0001641172-25-009950 2 16 BS 0 H Accounts Payable And Other Accrued Liabilities Current us-gaap/2024 Accounts and Other Payables 0
0001641172-25-009950 2 17 BS 0 H Short Term Borrowings us-gaap/2024 Short Term Debt 0
0001641172-25-009950 2 18 BS 0 H Long Term Debt Current us-gaap/2024 Current Portion of Long-Term Debt 0
0001641172-25-009950 2 19 BS 0 H Operating Lease Liability Current us-gaap/2024 Current Portion of Lease Liability 0
0001641172-25-009950 2 20 BS 0 H Liabilities Current us-gaap/2024 Total Current Liabilities 0
0001641172-25-009950 2 21 BS 0 H Long Term Debt Noncurrent us-gaap/2024 Long Term Debt 0
0001641172-25-009950 2 22 BS 0 H Operating Lease Liability Noncurrent us-gaap/2024 Long Term Lease Liability, Net of Current Portion 0
0001641172-25-009950 2 23 BS 0 H Liabilities us-gaap/2024 Total Liabilities 0
0001641172-25-009950 2 25 BS 0 H Preferred Stock Value us-gaap/2024 Preferred Stock, $0.00001 par value; 12,500,000 shares authorized, no preferred shares issued and outstanding as of March 31, 2025 and December 31, 2024, respectively 0
0001641172-25-009950 2 26 BS 0 H Common Stock Value us-gaap/2024 Common Stock, $0.00001 par value; 300,000,000 shares authorized; 2,808,071 and 2,808,071 shares issued and outstanding as of March 31, 2025 and December 31, 2024, respectively 0
0001641172-25-009950 2 27 BS 0 H Additional Paid In Capital us-gaap/2024 Additional Paid-In Capital 0
0001641172-25-009950 2 28 BS 0 H Accumulated Other Comprehensive Income Loss Net Of Tax us-gaap/2024 Accumulated Other Comprehensive Loss 0
0001641172-25-009950 2 29 BS 0 H Retained Earnings Accumulated Deficit us-gaap/2024 Accumulated Deficit 0
0001641172-25-009950 2 30 BS 0 H Stockholders Equity Including Portion Attributable To Noncontrolling Interest us-gaap/2024 Total Stockholders Equity 0
0001641172-25-009950 2 31 BS 0 H Liabilities And Stockholders Equity us-gaap/2024 Total Liabilities and Stockholders Equity 0
0001641172-25-009950 3 1 BS 1 H Preferred Stock Par Or Stated Value Per Share us-gaap/2024 Preferred stock, par value 0
0001641172-25-009950 3 2 BS 1 H Preferred Stock Shares Authorized us-gaap/2024 Preferred stock, shares authorized 0
0001641172-25-009950 3 3 BS 1 H Preferred Stock Shares Issued us-gaap/2024 Preferred stock, shares issued 0
0001641172-25-009950 3 4 BS 1 H Preferred Stock Shares Outstanding us-gaap/2024 Preferred stock, shares outstanding 0
0001641172-25-009950 3 5 BS 1 H Common Stock Par Or Stated Value Per Share us-gaap/2024 Common stock, par value 0
0001641172-25-009950 3 6 BS 1 H Common Stock Shares Authorized us-gaap/2024 Common stock, shares authorized 0
0001641172-25-009950 3 7 BS 1 H Common Stock Shares Issued us-gaap/2024 Common stock, shares issued 0
0001641172-25-009950 3 8 BS 1 H Common Stock Shares Outstanding us-gaap/2024 Common stock, shares outstanding 0
0001641172-25-009950 4 7 IS 0 H Revenue From Contract With Customer Excluding Assessed Tax us-gaap/2024 TOTAL REVENUE 0
0001641172-25-009950 4 8 IS 0 H Cost Of Revenue us-gaap/2024 COST OF REVENUE 0
0001641172-25-009950 4 9 IS 0 H Gross Profit us-gaap/2024 GROSS PROFIT 0
0001641172-25-009950 4 11 IS 0 H Selling General And Administrative Expense us-gaap/2024 General & Administrative 0
0001641172-25-009950 4 12 IS 0 H Research And Development Expense us-gaap/2024 Research & Development 0
0001641172-25-009950 4 13 IS 0 H Operating Expenses us-gaap/2024 Total Operating Expenses 0
0001641172-25-009950 4 14 IS 0 H Operating Income Loss us-gaap/2024 LOSS FROM OPERATIONS 0
0001641172-25-009950 4 16 IS 0 H Other Nonoperating Income Expense us-gaap/2024 Miscellaneous Income (Expense) 0
0001641172-25-009950 4 17 IS 0 H Investment Income Interest us-gaap/2024 Interest Income 0
0001641172-25-009950 4 18 IS 0 H Interest Expense Nonoperating us-gaap/2024 Interest Expense 1
0001641172-25-009950 4 19 IS 0 H Nonoperating Income Expense us-gaap/2024 Total Other Income (Expense), Net 0
0001641172-25-009950 4 20 IS 0 H Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest us-gaap/2024 LOSS BEFORE INCOME TAXES 0
0001641172-25-009950 4 21 IS 0 H Income Tax Expense Benefit us-gaap/2024 PROVISION FOR INCOME TAXES 1
0001641172-25-009950 4 22 IS 0 H Net Income Loss us-gaap/2024 NET LOSS 0
0001641172-25-009950 4 23 IS 0 H Earnings Per Share Basic us-gaap/2024 BASIC LOSS PER SHARE 0
0001641172-25-009950 4 24 IS 0 H Earnings Per Share Diluted us-gaap/2024 DILUTED LOSS PER SHARE 0
0001641172-25-009950 4 25 IS 0 H Weighted Average Number Of Shares Outstanding Basic us-gaap/2024 BASIC WEIGHTED AVERAGE SHARES 0
0001641172-25-009950 4 26 IS 0 H Weighted Average Number Of Diluted Shares Outstanding us-gaap/2024 DILUTED WEIGHTED AVERAGE SHARES 0
0001641172-25-009950 5 1 CI 0 H Net Income Loss us-gaap/2024 Net Loss 0
0001641172-25-009950 5 2 CI 0 H Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax us-gaap/2024 Change in Equity Adjustment from Foreign Currency Translation, Net of Tax 0
0001641172-25-009950 5 3 CI 0 H Comprehensive Income Net Of Tax us-gaap/2024 Comprehensive Loss 0
0001641172-25-009950 6 9 EQ 0 H Stockholders Equity Including Portion Attributable To Noncontrolling Interest us-gaap/2024 BALANCE 0
0001641172-25-009950 6 10 EQ 0 H Shares Outstanding us-gaap/2024 BALANCE, shares 0
0001641172-25-009950 6 11 EQ 0 H Adjustments To Additional Paid In Capital Other us-gaap/2024 Cost of Financing 0
0001641172-25-009950 6 12 EQ 0 H Net Income Loss us-gaap/2024 Net Loss 0
0001641172-25-009950 6 13 EQ 0 H Other Comprehensive Income Loss Net Of Tax us-gaap/2024 Comprehensive Loss 0
0001641172-25-009950 6 14 EQ 0 H Stockholders Equity Including Portion Attributable To Noncontrolling Interest us-gaap/2024 BALANCE 0
0001641172-25-009950 6 15 EQ 0 H Shares Outstanding us-gaap/2024 BALANCE, shares 0
0001641172-25-009950 7 2 CF 0 H Net Income Loss us-gaap/2024 Net Loss 0
0001641172-25-009950 7 4 CF 0 H Depreciation Depletion And Amortization us-gaap/2024 Depreciation and Amortization 0
0001641172-25-009950 7 6 CF 0 H Increase Decrease In Accounts Receivable us-gaap/2024 Accounts Receivable 1
0001641172-25-009950 7 7 CF 0 H Increase Decrease In Inventories us-gaap/2024 Inventory 1
0001641172-25-009950 7 8 CF 0 H Increase Decrease In Deferred Charges us-gaap/2024 Deferred Cost of Goods 1
0001641172-25-009950 7 9 CF 0 H Increase Decrease In Right Of Use Asset 0001641172-25-009950 Right of Use Asset 1
0001641172-25-009950 7 10 CF 0 H Increase Decrease In Other Current Assets us-gaap/2024 Other Current Assets 1
0001641172-25-009950 7 11 CF 0 H Increase Decrease In Other Noncurrent Assets us-gaap/2024 Other Assets 1
0001641172-25-009950 7 12 CF 0 H Increase Decrease In Other Accounts Payable us-gaap/2024 Increase (Decrease) in Accounts and Other Payables 0
0001641172-25-009950 7 13 CF 0 H Increase Decrease In Operating Lease Liability us-gaap/2024 Lease Liability 0
0001641172-25-009950 7 14 CF 0 H Net Cash Provided By Used In Operating Activities us-gaap/2024 Net Cash Used in Operating Activities 0
0001641172-25-009950 7 16 CF 0 H Proceeds From Sale Of Property Plant And Equipment us-gaap/2024 Purchase (Sale) of Property and Equipment 0
0001641172-25-009950 7 17 CF 0 H Net Cash Provided By Used In Investing Activities us-gaap/2024 Net Cash Used in Investing Activities 0
0001641172-25-009950 7 19 CF 0 H Proceeds From Repayments Of Short Term Debt us-gaap/2024 Proceeds from (Payments on ) Short-Term Debt, net 0
0001641172-25-009950 7 20 CF 0 H Proceeds From Repayments Of Notes Payable us-gaap/2024 Proceeds from (Payments on) Long-Term Debt 0
0001641172-25-009950 7 21 CF 0 H Proceeds From Issuance Of Common Stock us-gaap/2024 Common Stock Issued, Net of Cost of Financing 0
0001641172-25-009950 7 22 CF 0 H Net Cash Provided By Used In Financing Activities us-gaap/2024 Net Cash Provided by Financing Activities 0
0001641172-25-009950 7 23 CF 0 H Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations us-gaap/2024 EFFECT OF EXCHANGE RATE CHANGES ON CASH 0
0001641172-25-009950 7 24 CF 0 H Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect us-gaap/2024 NET DECREASE IN CASH, RESTRICTED CASH AND CASH EQUIVALENTS 0
0001641172-25-009950 7 25 CF 0 H Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations us-gaap/2024 Cash and Cash Equivalents- Beginning of Period 0
0001641172-25-009950 7 26 CF 0 H Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations us-gaap/2024 CASH AND CASH EQUIVALENTS - END OF PERIOD 0
0001641172-25-009950 7 28 CF 0 H Interest Paid Net us-gaap/2024 Interest Paid 0
0001641172-25-009950 7 29 CF 0 H Income Taxes Paid Net us-gaap/2024 Income Tax Paid 0
0001641172-25-009950 7 31 CF 0 H Present Value Of Right Of Use Asset And Lease Obligations On New Lease 0001641172-25-009950 Present Value of right of Use Asset and Lease Obligations on New Lease 0
0001641172-25-004833 2 8 BS 0 H Cash And Cash Equivalents At Carrying Value us-gaap/2024 Cash and Cash Equivalents 0
0001641172-25-004833 2 9 BS 0 H Restricted Cash us-gaap/2024 Restricted Cash 0
0001641172-25-004833 2 10 BS 0 H Accounts Receivable Net Current us-gaap/2024 Accounts Receivable, Net 0
0001641172-25-004833 2 11 BS 0 H Deferred Costs Current us-gaap/2024 Deferred Cost of Goods 0
0001641172-25-004833 2 12 BS 0 H Inventory Net us-gaap/2024 Inventory, Net 0
0001641172-25-004833 2 13 BS 0 H Other Assets Current us-gaap/2024 Other Current Assets 0
0001641172-25-004833 2 14 BS 0 H Assets Current us-gaap/2024 Total Current Assets 0
0001641172-25-004833 2 15 BS 0 H Property Plant And Equipment Net us-gaap/2024 PROPERTY AND EQUIPMENT, NET 0
0001641172-25-004833 2 16 BS 0 H Other Assets Noncurrent us-gaap/2024 Other Assets 0
0001641172-25-004833 2 17 BS 0 H Assets us-gaap/2024 Total Assets 0
0001641172-25-004833 2 20 BS 0 H Accounts Payable And Other Accrued Liabilities Current us-gaap/2024 Accounts and Other Payables 0
0001641172-25-004833 2 21 BS 0 H Short Term Borrowings us-gaap/2024 Short Term Debt 0
0001641172-25-004833 2 22 BS 0 H Long Term Debt Current us-gaap/2024 Current Portion of Long-Term Debt 0
0001641172-25-004833 2 23 BS 0 H Liabilities Current us-gaap/2024 Total Current Liabilities 0
0001641172-25-004833 2 24 BS 0 H Long Term Debt us-gaap/2024 LONG-TERM DEBT 0
0001641172-25-004833 2 26 BS 0 H Preferred Stock Value us-gaap/2024 Series B Preferred Stock, $0.00001 par value; 500 shares authorized, no shares issued and outstanding as of December 31, 2024 and December 31, 2023. 0
0001641172-25-004833 2 27 BS 0 H Common Stock Value us-gaap/2024 Common Stock, $0.00001 par value; 300,000,000 shares authorized; 2,808,071 and 2,021,236 shares issued and outstanding as of December 31, 2024 and December 31, 2023, respectively 0
0001641172-25-004833 2 28 BS 0 H Additional Paid In Capital us-gaap/2024 Additional Paid-In Capital 0
0001641172-25-004833 2 29 BS 0 H Accumulated Other Comprehensive Income Loss Net Of Tax us-gaap/2024 Accumulated Comprehensive Loss 0
0001641172-25-004833 2 30 BS 0 H Retained Earnings Accumulated Deficit us-gaap/2024 Accumulated Deficit 0
0001641172-25-004833 2 31 BS 0 H Stockholders Equity Including Portion Attributable To Noncontrolling Interest us-gaap/2024 Total Stockholders Equity 0
0001641172-25-004833 2 32 BS 0 H Liabilities And Stockholders Equity us-gaap/2024 Total Liabilities and Stockholders Equity 0
0001641172-25-004833 3 6 BS 1 H Preferred Stock Par Or Stated Value Per Share us-gaap/2024 Preferred Stock, par value 0
0001641172-25-004833 3 7 BS 1 H Preferred Stock Shares Authorized us-gaap/2024 Preferred stock, shares authorized 0
0001641172-25-004833 3 8 BS 1 H Preferred Stock Shares Issued us-gaap/2024 Preferred stock, shares issued 0
0001641172-25-004833 3 9 BS 1 H Preferred Stock Shares Outstanding us-gaap/2024 Preferred stock, shares outstanding 0
0001641172-25-004833 3 10 BS 1 H Common Stock Par Or Stated Value Per Share us-gaap/2024 Common stock, par value 0
0001641172-25-004833 3 11 BS 1 H Common Stock Shares Authorized us-gaap/2024 Common stock, shares authorized 0
0001641172-25-004833 3 12 BS 1 H Common Stock Shares Issued us-gaap/2024 Common stock, shares issued 0
0001641172-25-004833 3 13 BS 1 H Common Stock Shares Outstanding us-gaap/2024 Common stock, shares outstanding 0
0001641172-25-004833 4 8 IS 0 H Revenue From Contract With Customer Excluding Assessed Tax us-gaap/2024 TOTAL REVENUE 0
0001641172-25-004833 4 9 IS 0 H Cost Of Revenue us-gaap/2024 COST OF REVENUE 0
0001641172-25-004833 4 10 IS 0 H Gross Profit us-gaap/2024 GROSS PROFIT 0
0001641172-25-004833 4 12 IS 0 H Selling General And Administrative Expense us-gaap/2024 General & Administrative 0
0001641172-25-004833 4 13 IS 0 H Research And Development Expense us-gaap/2024 Research and Development 0
0001641172-25-004833 4 14 IS 0 H Operating Expenses us-gaap/2024 Total Operating Expenses 0
0001641172-25-004833 4 15 IS 0 H Operating Income Loss us-gaap/2024 LOSS FROM OPERATIONS 0
0001641172-25-004833 4 17 IS 0 H Other Nonoperating Income Expense us-gaap/2024 Miscellaneous Income (Expense) 0
0001641172-25-004833 4 18 IS 0 H Gain Loss On Investments us-gaap/2024 Loss from investment in Iveda Phils JV 0
0001641172-25-004833 4 19 IS 0 H Investment Income Interest us-gaap/2024 Interest Income 0
0001641172-25-004833 4 20 IS 0 H Interest Expense Nonoperating us-gaap/2024 Interest Expense 1
0001641172-25-004833 4 21 IS 0 H Nonoperating Income Expense us-gaap/2024 Total Other Income (Expense) 0
0001641172-25-004833 4 22 IS 0 H Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest us-gaap/2024 LOSS BEFORE INCOME TAXES 0
0001641172-25-004833 4 23 IS 0 H Income Tax Expense Benefit us-gaap/2024 BENEFIT (PROVISION) FOR INCOME TAXES 1
0001641172-25-004833 4 24 IS 0 H Net Income Loss us-gaap/2024 NET LOSS 0
0001641172-25-004833 4 25 IS 0 H Earnings Per Share Basic us-gaap/2024 BASIC LOSS PER SHARE 0
0001641172-25-004833 4 26 IS 0 H Earnings Per Share Diluted us-gaap/2024 DILUTED LOSS PER SHARE 0
0001641172-25-004833 4 27 IS 0 H Weighted Average Number Of Shares Outstanding Basic us-gaap/2024 BASIC WEIGHTED AVERAGE SHARES 0
0001641172-25-004833 4 28 IS 0 H Weighted Average Number Of Diluted Shares Outstanding us-gaap/2024 DILUTED WEIGHTED AVERAGE SHARES 0
0001641172-25-004833 5 1 CI 0 H Net Income Loss us-gaap/2024 Net Loss 0
0001641172-25-004833 5 2 CI 0 H Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax us-gaap/2024 Foreign Currency Translation, Net of Tax 0
0001641172-25-004833 5 3 CI 0 H Comprehensive Income Net Of Tax us-gaap/2024 Comprehensive Loss 0
0001641172-25-004833 6 12 EQ 0 H Stockholders Equity Including Portion Attributable To Noncontrolling Interest us-gaap/2024 BALANCE 0
0001641172-25-004833 6 13 EQ 0 H Shares Outstanding us-gaap/2024 BALANCE, shares 0
0001641172-25-004833 6 14 EQ 0 H Deferred Income Tax Effects To Equity Prior Period Adjustment 0001641172-25-004833 Prior Period Adjustments 1
0001641172-25-004833 6 15 EQ 0 H Stock Issued During Period Value Stock Warrants Exercised 0001641172-25-004833 Exercise of warrants issued August 2022 0
0001641172-25-004833 6 16 EQ 0 H Stock Issued During Period Shares Stock Warrants Exercised 0001641172-25-004833 Exercise of warrants issued August 2022, shares 0
0001641172-25-004833 6 17 EQ 0 H Adjustments To Additional Paid In Capital Warrant Issued us-gaap/2024 Warrants issued for services 0
0001641172-25-004833 6 18 EQ 0 H Stock Issued During Period Value Issued For Services us-gaap/2024 Common Stock for Services 0
0001641172-25-004833 6 19 EQ 0 H Stock Issued During Period Shares Issued For Services us-gaap/2024 Common Stock for Services, shares 0
0001641172-25-004833 6 20 EQ 0 H Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value us-gaap/2024 Stock Option Compensation 0
0001641172-25-004833 6 21 EQ 0 H Net Income Loss us-gaap/2024 Net Loss 0
0001641172-25-004833 6 22 EQ 0 H Other Comprehensive Income Loss Net Of Tax us-gaap/2024 Comprehensive Loss 0
0001641172-25-004833 6 23 EQ 0 H Stock Issued During Period Value New Issues us-gaap/2024 Common Stock Issued in September Direct Offering (including Pre-Funded Warrants sold and exercised 0
0001641172-25-004833 6 24 EQ 0 H Stock Issued During Period Shares New Issues us-gaap/2024 Common Stock Issued in September Offering, shares 0
0001641172-25-004833 6 25 EQ 0 H Stock Issued During Reverse Split Fractional Shares Value 0001641172-25-004833 Reverse Split fractional shares 0
0001641172-25-004833 6 26 EQ 0 H Stock Issued During Reverse Split Fractional Shares 0001641172-25-004833 Reverse Split fractional shares, shares 0
0001641172-25-004833 6 27 EQ 0 H Stockholders Equity Including Portion Attributable To Noncontrolling Interest us-gaap/2024 BALANCE 0
0001641172-25-004833 6 28 EQ 0 H Shares Outstanding us-gaap/2024 BALANCE, shares 0
0001641172-25-004833 8 2 CF 0 H Net Income Loss us-gaap/2024 Net Loss 0
0001641172-25-004833 8 4 CF 0 H Depreciation Depletion And Amortization us-gaap/2024 Depreciation and Amortization 0
0001641172-25-004833 8 5 CF 0 H Share Based Compensation us-gaap/2024 Stock Option Compensation 0
0001641172-25-004833 8 6 CF 0 H Common Stock Warrants Issued For Services 0001641172-25-004833 Common Stock Warrants Issued for Services 0
0001641172-25-004833 8 7 CF 0 H Common Stock Issued For Services 0001641172-25-004833 Common Stock issued for Services 0
0001641172-25-004833 8 8 CF 0 H Income Loss From Equity Method Investments us-gaap/2024 Loss from Iveda Phils Joint Venture 1
0001641172-25-004833 8 10 CF 0 H Increase Decrease In Accounts Receivable us-gaap/2024 Accounts Receivable 1
0001641172-25-004833 8 11 CF 0 H Increase Decrease In Deferred Charges us-gaap/2024 Deferred Cost of Goods 1
0001641172-25-004833 8 12 CF 0 H Increase Decrease In Inventories us-gaap/2024 Inventory 1
0001641172-25-004833 8 13 CF 0 H Increase Decrease In Other Current Assets us-gaap/2024 Other Current Assets 1
0001641172-25-004833 8 14 CF 0 H Increase Decrease In Other Noncurrent Assets us-gaap/2024 Other Assets 1
0001641172-25-004833 8 15 CF 0 H Increase Decrease In Other Accounts Payable us-gaap/2024 Increase (Decrease) in Accounts and Other Payables 0
0001641172-25-004833 8 16 CF 0 H Net Cash Provided By Used In Operating Activities us-gaap/2024 Net Cash Used in Operating Activities 0
0001641172-25-004833 8 18 CF 0 H Payments To Acquire Property Plant And Equipment us-gaap/2024 Purchase of Property and Equipment 1
0001641172-25-004833 8 19 CF 0 H Payments To Acquire Equity Securities Fv Ni us-gaap/2024 Investment in Iveda Phils Joint Venture 1
0001641172-25-004833 8 20 CF 0 H Net Cash Provided By Used In Investing Activities us-gaap/2024 Net Cash Used in Investing Activities 0
0001641172-25-004833 8 22 CF 0 H Proceeds From Repayments Of Short Term Debt us-gaap/2024 Proceeds from (Payments on) Short-Term Notes Payable/Debt 0
0001641172-25-004833 8 23 CF 0 H Proceeds From Repayments Of Notes Payable us-gaap/2024 Proceeds from (Payments to) Long-Term Debt 0
0001641172-25-004833 8 24 CF 0 H Proceeds From Issuance Of Common Stock us-gaap/2024 Common Stock Issued, Net of (Cost of Capital) 0
0001641172-25-004833 8 25 CF 0 H Net Cash Provided By Used In Financing Activities us-gaap/2024 Net Cash Provided by Financing Activities 0
0001641172-25-004833 8 26 CF 0 H Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations us-gaap/2024 EFFECT OF EXCHANGE RATE CHANGES ON CASH 0
0001641172-25-004833 8 27 CF 0 H Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect us-gaap/2024 NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS 0
0001641172-25-004833 8 28 CF 0 H Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations us-gaap/2024 Cash and Cash Equivalents- Beginning of Period 0
0001641172-25-004833 8 29 CF 0 H Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations us-gaap/2024 CASH AND CASH EQUIVALENTS - END OF PERIOD 0
0001641172-25-004833 8 31 CF 0 H Interest Paid Net us-gaap/2024 Interest Paid 0
0001641172-25-004833 8 32 CF 0 H Income Taxes Paid Net us-gaap/2024 Income Tax Paid 0
0001641172-25-015284 2 9 BS 0 H Restricted Cash us-gaap/2024 Restricted Cash 0
0001641172-25-015284 2 10 BS 0 H Accounts Receivable Net Current us-gaap/2024 Accounts Receivable, Net 0
0001641172-25-015284 2 11 BS 0 H Deferred Costs Current us-gaap/2024 Deferred Cost of Goods 0
0001641172-25-015284 2 12 BS 0 H Inventory Net us-gaap/2024 Inventory, Net 0
0001641172-25-015284 2 13 BS 0 H Other Assets Current us-gaap/2024 Other Current Assets 0
0001641172-25-015284 2 14 BS 0 H Assets Current us-gaap/2024 Total Current Assets 0
0001641172-25-015284 2 15 BS 0 H Property Plant And Equipment Net us-gaap/2024 PROPERTY AND EQUIPMENT, NET 0
0001641172-25-015284 2 16 BS 0 H Other Assets Noncurrent us-gaap/2024 Other Assets 0
0001641172-25-015284 2 17 BS 0 H Assets us-gaap/2024 Total Assets 0
0001641172-25-015284 2 20 BS 0 H Accounts Payable And Other Accrued Liabilities Current us-gaap/2024 Accounts and Other Payables 0
0001641172-25-015284 2 21 BS 0 H Short Term Borrowings us-gaap/2024 Short Term Debt 0
0001641172-25-015284 2 22 BS 0 H Long Term Debt Current us-gaap/2024 Current Portion of Long-Term Debt 0
0001641172-25-015284 2 23 BS 0 H Liabilities Current us-gaap/2024 Total Current Liabilities 0
0001641172-25-015284 2 24 BS 0 H Long Term Debt us-gaap/2024 LONG-TERM DEBT 0
0001641172-25-015284 2 26 BS 0 H Preferred Stock Value us-gaap/2024 Series B Preferred Stock, $0.00001 par value; 500 shares authorized, no shares issued and outstanding as of December 31, 2024 and December 31, 2023. 0
0001641172-25-015284 2 27 BS 0 H Common Stock Value us-gaap/2024 Common Stock, $0.00001 par value; 300,000,000 shares authorized; 2,808,071 and 2,021,236 shares issued and outstanding as of December 31, 2024 and December 31, 2023, respectively 0
0001641172-25-015284 2 28 BS 0 H Additional Paid In Capital us-gaap/2024 Additional Paid-In Capital 0
0001641172-25-015284 2 29 BS 0 H Accumulated Other Comprehensive Income Loss Net Of Tax us-gaap/2024 Accumulated Comprehensive Loss 0
0001641172-25-015284 2 30 BS 0 H Retained Earnings Accumulated Deficit us-gaap/2024 Accumulated Deficit 0
0001641172-25-015284 2 31 BS 0 H Stockholders Equity Including Portion Attributable To Noncontrolling Interest us-gaap/2024 Total Stockholders Equity 0
0001641172-25-015284 2 32 BS 0 H Liabilities And Stockholders Equity us-gaap/2024 Total Liabilities and Stockholders Equity 0
0001641172-25-015284 3 6 BS 1 H Preferred Stock Par Or Stated Value Per Share us-gaap/2024 Preferred Stock, par value 0
0001641172-25-015284 3 7 BS 1 H Preferred Stock Shares Authorized us-gaap/2024 Preferred stock, shares authorized 0
0001641172-25-015284 3 8 BS 1 H Preferred Stock Shares Issued us-gaap/2024 Preferred stock, shares issued 0
0001641172-25-015284 3 9 BS 1 H Preferred Stock Shares Outstanding us-gaap/2024 Preferred stock, shares outstanding 0
0001641172-25-015284 3 10 BS 1 H Common Stock Par Or Stated Value Per Share us-gaap/2024 Common stock, par value 0
0001641172-25-015284 3 11 BS 1 H Common Stock Shares Authorized us-gaap/2024 Common stock, shares authorized 0
0001641172-25-015284 3 12 BS 1 H Common Stock Shares Issued us-gaap/2024 Common stock, shares issued 0
0001641172-25-015284 3 13 BS 1 H Common Stock Shares Outstanding us-gaap/2024 Common stock, shares outstanding 0
0001641172-25-015284 4 8 IS 0 H Revenue From Contract With Customer Excluding Assessed Tax us-gaap/2024 TOTAL REVENUE 0
0001641172-25-015284 4 9 IS 0 H Cost Of Revenue us-gaap/2024 COST OF REVENUE 0
0001641172-25-015284 4 10 IS 0 H Gross Profit us-gaap/2024 GROSS PROFIT 0
0001641172-25-015284 4 12 IS 0 H Selling General And Administrative Expense us-gaap/2024 General & Administrative 0
0001641172-25-015284 4 13 IS 0 H Research And Development Expense us-gaap/2024 Research and Development 0
0001641172-25-015284 4 14 IS 0 H Operating Expenses us-gaap/2024 Total Operating Expenses 0
0001641172-25-015284 4 15 IS 0 H Operating Income Loss us-gaap/2024 LOSS FROM OPERATIONS 0
0001641172-25-015284 4 17 IS 0 H Other Nonoperating Income Expense us-gaap/2024 Miscellaneous Income (Expense) 0
0001641172-25-015284 4 18 IS 0 H Gain Loss On Investments us-gaap/2024 Loss from investment in Iveda Phils JV 0
0001641172-25-015284 4 19 IS 0 H Investment Income Interest us-gaap/2024 Interest Income 0
0001641172-25-015284 4 20 IS 0 H Interest Expense Nonoperating us-gaap/2024 Interest Expense 1
0001641172-25-015284 4 21 IS 0 H Nonoperating Income Expense us-gaap/2024 Total Other Income (Expense) 0
0001641172-25-015284 4 22 IS 0 H Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest us-gaap/2024 LOSS BEFORE INCOME TAXES 0
0001641172-25-015284 4 23 IS 0 H Income Tax Expense Benefit us-gaap/2024 BENEFIT (PROVISION) FOR INCOME TAXES 1
0001641172-25-015284 4 24 IS 0 H Net Income Loss us-gaap/2024 NET LOSS 0
0001641172-25-015284 4 25 IS 0 H Earnings Per Share Basic us-gaap/2024 BASIC LOSS PER SHARE 0
0001641172-25-015284 4 26 IS 0 H Earnings Per Share Diluted us-gaap/2024 DILUTED LOSS PER SHARE 0
0001641172-25-015284 4 27 IS 0 H Weighted Average Number Of Shares Outstanding Basic us-gaap/2024 BASIC WEIGHTED AVERAGE SHARES 0
0001641172-25-015284 4 28 IS 0 H Weighted Average Number Of Diluted Shares Outstanding us-gaap/2024 DILUTED WEIGHTED AVERAGE SHARES 0
0001641172-25-015284 5 1 CI 0 H Net Income Loss us-gaap/2024 Net Loss 0
0001641172-25-015284 5 2 CI 0 H Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax us-gaap/2024 Foreign Currency Translation, Net of Tax 0
0001641172-25-015284 5 3 CI 0 H Comprehensive Income Net Of Tax us-gaap/2024 Comprehensive Loss 0
0001641172-25-015284 6 12 EQ 0 H Stockholders Equity Including Portion Attributable To Noncontrolling Interest us-gaap/2024 BALANCE 0
0001641172-25-015284 6 13 EQ 0 H Shares Outstanding us-gaap/2024 BALANCE, shares 0
0001641172-25-015284 6 14 EQ 0 H Deferred Income Tax Effects To Equity Prior Period Adjustment 0001641172-25-015284 Prior Period Adjustments 1
0001641172-25-015284 6 15 EQ 0 H Stock Issued During Period Value Stock Warrants Exercised 0001641172-25-015284 Exercise of warrants issued August 2022 0
0001641172-25-015284 6 16 EQ 0 H Stock Issued During Period Shares Stock Warrants Exercised 0001641172-25-015284 Exercise of warrants issued August 2022, shares 0
0001641172-25-015284 6 17 EQ 0 H Adjustments To Additional Paid In Capital Warrant Issued us-gaap/2024 Warrants issued for services 0
0001641172-25-015284 6 18 EQ 0 H Stock Issued During Period Value Issued For Services us-gaap/2024 Common Stock for Services 0
0001641172-25-015284 6 19 EQ 0 H Stock Issued During Period Shares Issued For Services us-gaap/2024 Common Stock for Services, shares 0
0001641172-25-015284 6 20 EQ 0 H Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value us-gaap/2024 Stock Option Compensation 0
0001641172-25-015284 6 21 EQ 0 H Net Income Loss us-gaap/2024 Net Loss 0
0001641172-25-015284 6 22 EQ 0 H Other Comprehensive Income Loss Net Of Tax us-gaap/2024 Comprehensive Loss 0
0001641172-25-015284 6 23 EQ 0 H Stock Issued During Period Value New Issues us-gaap/2024 Common Stock Issued in September Direct Offering (including Pre-Funded Warrants sold and exercised 0
0001641172-25-015284 6 24 EQ 0 H Stock Issued During Period Shares New Issues us-gaap/2024 Common Stock Issued in September Offering, shares 0
0001641172-25-015284 6 25 EQ 0 H Stock Issued During Reverse Split Fractional Shares Value 0001641172-25-015284 Reverse Split fractional shares 0
0001641172-25-015284 6 26 EQ 0 H Stock Issued During Reverse Split Fractional Shares 0001641172-25-015284 Reverse Split fractional shares, shares 0
0001641172-25-015284 6 27 EQ 0 H Stockholders Equity Including Portion Attributable To Noncontrolling Interest us-gaap/2024 BALANCE 0
0001641172-25-015284 6 28 EQ 0 H Shares Outstanding us-gaap/2024 BALANCE, shares 0
0001641172-25-015284 8 2 CF 0 H Net Income Loss us-gaap/2024 Net Loss 0
0001641172-25-015284 8 4 CF 0 H Depreciation Depletion And Amortization us-gaap/2024 Depreciation and Amortization 0
0001641172-25-015284 8 5 CF 0 H Share Based Compensation us-gaap/2024 Stock Option Compensation 0
0001641172-25-015284 8 6 CF 0 H Common Stock Warrants Issued For Services 0001641172-25-015284 Common Stock Warrants Issued for Services 0
0001641172-25-015284 8 7 CF 0 H Common Stock Issued For Services 0001641172-25-015284 Common Stock issued for Services 0
0001641172-25-015284 8 8 CF 0 H Income Loss From Equity Method Investments us-gaap/2024 Loss from Iveda Phils Joint Venture 1
0001641172-25-015284 8 10 CF 0 H Increase Decrease In Accounts Receivable us-gaap/2024 Accounts Receivable 1
0001641172-25-015284 8 11 CF 0 H Increase Decrease In Deferred Charges us-gaap/2024 Deferred Cost of Goods 1
0001641172-25-015284 8 12 CF 0 H Increase Decrease In Inventories us-gaap/2024 Inventory 1
0001641172-25-015284 8 13 CF 0 H Increase Decrease In Other Current Assets us-gaap/2024 Other Current Assets 1
0001641172-25-015284 8 14 CF 0 H Increase Decrease In Other Noncurrent Assets us-gaap/2024 Other Assets 1
0001641172-25-015284 8 15 CF 0 H Increase Decrease In Other Accounts Payable us-gaap/2024 Increase (Decrease) in Accounts and Other Payables 0
0001641172-25-015284 8 16 CF 0 H Net Cash Provided By Used In Operating Activities us-gaap/2024 Net Cash Used in Operating Activities 0
0001641172-25-015284 8 18 CF 0 H Payments To Acquire Other Property Plant And Equipment us-gaap/2024 Purchase of Property and Equipment 1
0001641172-25-015284 8 19 CF 0 H Payments To Acquire Equity Securities Fv Ni us-gaap/2024 Investment in Iveda Phils Joint Venture 1
0001641172-25-015284 8 20 CF 0 H Net Cash Provided By Used In Investing Activities us-gaap/2024 Net Cash Used in Investing Activities 0
0001641172-25-015284 8 22 CF 0 H Proceeds From Repayments Of Short Term Debt us-gaap/2024 Proceeds from (Payments on) Short-Term Notes Payable/Debt 0
0001641172-25-015284 8 23 CF 0 H Proceeds From Repayments Of Notes Payable us-gaap/2024 Proceeds from (Payments to) Long-Term Debt 0
0001641172-25-015284 8 24 CF 0 H Proceeds From Issuance Of Common Stock us-gaap/2024 Common Stock Issued, Net of (Cost of Capital) 0
0001641172-25-015284 8 25 CF 0 H Net Cash Provided By Used In Financing Activities us-gaap/2024 Net Cash Provided by Financing Activities 0
0001641172-25-015284 8 26 CF 0 H Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations us-gaap/2024 EFFECT OF EXCHANGE RATE CHANGES ON CASH 0
0001641172-25-015284 8 27 CF 0 H Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect us-gaap/2024 NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS 0
0001641172-25-015284 8 28 CF 0 H Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations us-gaap/2024 Cash and Cash Equivalents- Beginning of Period 0
0001641172-25-015284 8 29 CF 0 H Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations us-gaap/2024 CASH AND CASH EQUIVALENTS - END OF PERIOD 0
0001641172-25-015284 8 31 CF 0 H Interest Paid Net us-gaap/2024 Interest Paid 0
0001641172-25-015284 8 32 CF 0 H Income Taxes Paid Net us-gaap/2024 Income Tax Paid 0

Description
Field Name Field Description
adsh Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission.
report Represents the report grouping. This field corresponds to the statement (stmt) field, which indicates the type of statement. The numeric value refers to the “R file” as posted on the EDGAR Web site.
line Represents the tag’s presentation line order for a given report. Together with the statement and report field, presentation location, order and grouping can be derived.
stmt The financial statement location to which the value of the “report” field pertains.
inpth Value was presented “parenthetically” instead of in columns within the financial statements. For example: Receivables (net of allowance for bad debts of $200 in 2012) $700.
rfile The type of interactive data file rendered on the EDGAR web site, H = .htm file, X = .xml file.
tag The tag chosen by the filer for this line item.
version The taxonomy identifier if the tag is a standard tag, otherwise adsh.
plabel The text presented on the line item, also known as a “preferred” label.
negating Flag to indicate whether the plabel is negating.